{"content":"<li class=\"n-box-item date-title\" data-end=\"1505447999\" data-start=\"1505361600\" data-txt=\"Monday, December 23, 2019\">Thursday, September 14, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3295637\" data-ts=\"1505430586\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KITE\" target=\"_blank\">KITE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295637-gilead-sciences-prices-3b-in-debt-for-kite-pharma-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gilead Sciences prices $3B in debt for Kite Pharma deal</a></h4><ul>   <li>Gilead Sciences (<a href=\"http://seekingalpha.com/symbol/GILD\" target=\"_blank\">GILD</a> <font color='red'>-1.7%</font>) has <a href=\"https://seekingalpha.com/pr/16941790-gilead-prices-3-billion-senior-unsecured-notes\" target=\"_blank\">priced $3B of senior unsecured debt</a>, in four tranches, to help fund its $11.9B acquisition of Kite Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/KITE' title='Kite Pharma'>KITE</a>).</li>    <li>The company priced $750M in floating-rate notes, maturing September 2018; $750M in floating-rate notes maturing March 2019; $500M in floating-rate notes maturing September 2019; and $1B in 1.85B senior notes maturing in 2019.</li>    <li>Net proceeds will finance part of the cash consideration in the Kite Pharma deal.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3295637\" data-linked=\"Gilead Sciences prices $3B in debt for Kite Pharma deal\" data-tweet=\"$KITE $KITE $GILD - Gilead Sciences prices $3B in debt for Kite Pharma deal https://seekingalpha.com/news/3295637-gilead-sciences-prices-3b-in-debt-for-kite-pharma-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3295637-gilead-sciences-prices-3b-in-debt-for-kite-pharma-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295635\" data-ts=\"1505429685\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTDOY\" target=\"_blank\">NTDOY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295635-videogame-sales-take-pre-holiday-breather-falling-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Videogame sales take a pre-holiday breather, falling 2%</a></h4><ul>   <li>Videogame sales reversed last month's gains, falling overall and in hardware and software after a multi-month run of strength from consoles following the release of the Nintendo Switch (<a href=\"http://seekingalpha.com/symbol/NTDOY\" target=\"_blank\">NTDOY</a> <font color='green'>+1%</font>).</li>    <li>Overall sales fell 2% Y/Y to $568M, according to NPD Group. Hardware reversed course to fall 6%, to $168M; software (console and portable) declined 2% to $271M, and PC game software (physical and via Steam) fell 23% to $11M.</li>    <li>Accessory spending was a bright spot, gaining 10% Y/Y to $118M.</li>    <li>In individual games, <i>Madden NFL 18</i> (<a href=\"http://seekingalpha.com/symbol/EA\" target=\"_blank\">EA</a> <font color='red'>-0.3%</font>) took its place atop the dollar sales chart, followed by perpetual workhorse <i>Grand Theft Auto V</i> (<a href=\"http://seekingalpha.com/symbol/TTWO\" target=\"_blank\">TTWO</a> <font color='green'>+0.6%</font>), in its 49th month on the market.</li>    <li><i>GTA V</i> is the all-time best-selling game by both revenue and units in tracked sales across PC, console and portable with digital and packaged combined, NPD's Mat Piscatella notes.</li>    <li>Rounding out the top 10 in software: No. 3, <i>Uncharted: The Lost Legacy</i> (<a href=\"http://seekingalpha.com/symbol/SNE\" target=\"_blank\">SNE</a> <font color='red'>-3.5%</font>); No. 4, <i>Splatoon 2</i> (<a href='https://seekingalpha.com/symbol/NTDOY' title='Nintendo Co., Ltd. ADR'>OTCPK:NTDOY</a>); No. 5, <i>The Legend of Zelda: Breath of the Wild</i> (<a href='https://seekingalpha.com/symbol/NTDOY' title='Nintendo Co., Ltd. ADR'>OTCPK:NTDOY</a>); No. 6, <i>Tom Clancy's Rainbox Six: Siege</i> (<a href=\"http://seekingalpha.com/symbol/UBSFY\" target=\"_blank\">UBSFY</a> <font color='green'>+0.4%</font>); No. 7, <i>Mario Kart 8</i> (<a href='https://seekingalpha.com/symbol/NTDOY' title='Nintendo Co., Ltd. ADR'>OTCPK:NTDOY</a>); No. 8, <i>Call of Duty: Modern Warfare Remastered</i> (<a href=\"http://seekingalpha.com/symbol/ATVI\" target=\"_blank\">ATVI</a> <font color='red'>-0.4%</font>); No. 9, <i>Crash Bandicoot: N. Sane Trilogy</i> (NASDAQ:<a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc'>ATVI</a>); No. 10, <i>Overwatch</i> (<a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc'>ATVI</a>).</li>    <li>Once again, the Switch was the best-selling hardware platform, while PlayStation 4 continues to lead YTD sales. Despite this month's fall-off, YTD hardware spending is still up 17%, to $1.7B.</li><li>ETF: <a href='https://seekingalpha.com/symbol/GAMR' title='PureFunds Video Game Tech ETF'>GAMR</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3295635\" data-linked=\"Videogame sales take a pre-holiday breather, falling 2%\" data-tweet=\"$NTDOY $NTDOY $ATVI - Videogame sales take a pre-holiday breather, falling 2% https://seekingalpha.com/news/3295635-videogame-sales-take-pre-holiday-breather-falling-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3295635-videogame-sales-take-pre-holiday-breather-falling-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295630\" data-ts=\"1505426171\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTZ\" target=\"_blank\">HTZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295630-hertz-prices-800m-private-asset-backed-debt-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hertz prices $800M private asset-backed debt offering</a></h4><ul>   <li>Hertz Global Holdings (<a href=\"http://seekingalpha.com/symbol/HTZ\" target=\"_blank\">HTZ</a> <font color='red'>-12.4%</font>) says its special-purpose subsidiary has <a href=\"https://seekingalpha.com/pr/16941758-hertz-global-holdings-announces-pricing-private-offering-800_0-million-medium-term-rental-car\" target=\"_blank\">priced an $800M private offering</a> of notes backed by rental car assets.</li>    <li>Hertz Vehicle Financing II LP priced $450M in a series of notes at a weighted average interest rate of 3.38%, and $350M in a series at a weighted average interest of 3.57%.</li>    <li>The first series has four classes in cascading subordination (Class A, Class B, Class C and Class D) and the second series has three such classes (the fourth class will be retained).</li>    <li>Net proceeds will go to make loans to Hertz Vehicle Financing and/or to repay part of the subsidiary's variable funding notes.</li>    <li>After hours: <a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a> <font color='green'>+0.3%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3295371-morgan-stanley-sees-hertz-global-rally-played\" target=\"_blank\">Morgan Stanley sees Hertz Global rally played out</a> (Sep. 14 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3295630\" data-linked=\"Hertz prices $800M private asset-backed debt offering\" data-tweet=\"$HTZ - Hertz prices $800M private asset-backed debt offering https://seekingalpha.com/news/3295630-hertz-prices-800m-private-asset-backed-debt-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3295630-hertz-prices-800m-private-asset-backed-debt-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295629\" data-ts=\"1505425536\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRTX\" target=\"_blank\">MRTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295629-mirati-therapeuticsplus-63-on-clinical-trial-data-for-lung-cancer-treatment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mirati Therapeutics +63% on clinical trial data for lung cancer treatment</a></h4><ul>     <li>Mirati Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MRTX' title='Mirati Therapeutics, Inc.'>MRTX</a>)&nbsp;<font color='green'>+63.1%</font>&nbsp;AH after presenting <a href=\"https://seekingalpha.com/pr/16941678-mirati-therapeutics-presents-positive-preliminary-data-going-clinical-trials-sitravatinib-non\" target=\"_blank\">positive preliminary data</a> from two ongoing clinical trials of sitravatinib in non-small cell lung cancer.</li>     <li>MRTX says initial safety data and efficacy information will be presented from the ongoing Phase 2 study of sitravatinib in combination with nivolumab as a treatment for non-small cell lung cancer patients, and a case study will be presented that  documents an objective response of a NSCLC patient with a CBL inactivating mutation.</li><li>In both clinical studies, sitravatinib alone and in combination with nivolumab was well tolerated with a  manageable safety profile.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3295629\" data-linked=\"Mirati Therapeutics +63% on clinical trial data for lung cancer treatment\" data-tweet=\"$MRTX - Mirati Therapeutics +63% on clinical trial data for lung cancer treatment https://seekingalpha.com/news/3295629-mirati-therapeuticsplus-63-on-clinical-trial-data-for-lung-cancer-treatment?source=tweet\" data-url=\"https://seekingalpha.com/news/3295629-mirati-therapeuticsplus-63-on-clinical-trial-data-for-lung-cancer-treatment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295627\" data-ts=\"1505425183\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TV\" target=\"_blank\">TV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295627-televisa-intelsat-extend-tv-distribution-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Televisa, Intelsat extend TV distribution deal</a></h4><ul>   <li>Grupo Televisa (<a href=\"http://seekingalpha.com/symbol/TV\" target=\"_blank\">TV</a> <font color='red'>-0.6%</font>) and Intelsat (<a href=\"http://seekingalpha.com/symbol/I\" target=\"_blank\">I</a> <font color='green'>+8%</font>) are extending their partnership with a <a href=\"https://seekingalpha.com/pr/16940666-grupo-televisa-extends-partnership-leverage-intelsat-s-high-performance-galaxy-satellites\" target=\"_blank\">multi-year agreement</a>.</li>    <li>The multi-transponder deal means Televisa will distribute its over-the-air networks through C-band services on Intelsat's Galaxy 16 and Galaxy 19 satellites to deliver in Mexico.</li>    <li>The two satellites deliver broadcast network distribution throughout North America.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3295627\" data-linked=\"Televisa, Intelsat extend TV distribution deal\" data-tweet=\"$TV $TV $I - Televisa, Intelsat extend TV distribution deal https://seekingalpha.com/news/3295627-televisa-intelsat-extend-tv-distribution-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3295627-televisa-intelsat-extend-tv-distribution-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295626\" data-ts=\"1505425162\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295626-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/HIBB' title='Hibbett Sports, Inc.'>HIBB</a> <font color='green'>+6.4%</font>. <a href='https://seekingalpha.com/symbol/TNP' title='Tsakos Energy Navigation Limited'>TNP</a> <font color='green'>+6.3%</font>. <a href='https://seekingalpha.com/symbol/GNW' title='Genworth Financial, Inc.'>GNW</a> <font color='green'>+5.5%</font>. <a href='https://seekingalpha.com/symbol/BGFV' title='Big 5 Sporting Goods Corporation'>BGFV</a> <font color='green'>+4.5%</font>. <a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a> <font color='green'>+3.7%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/TTOO' title='T2 Biosystems'>TTOO</a> <font color='red'>-19.3%</font>. <a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a> <font color='red'>-4.7%</font>. <a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a> <font color='red'>-2.0%</font>. <a href='https://seekingalpha.com/symbol/OUT' title='Outfront Media, Inc.'>OUT</a> <font color='red'>-2.0%</font>. <a href='https://seekingalpha.com/symbol/GKOS' title='Glaukos'>GKOS</a> <font color='red'>-1.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3295626\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$HIBB $TNP $GNW - After Hours Gainers / Losers https://seekingalpha.com/news/3295626-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3295626-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295625\" data-ts=\"1505425146\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNW\" target=\"_blank\">GNW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295625-genworthplus-8_8-virginia-approves-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genworth +8.8% as Virginia approves sale</a></h4><ul><li>Virginia has given the green light to the sale of at least Genworth's (NYSE:<a href='https://seekingalpha.com/symbol/GNW' title='Genworth Financial, Inc.'>GNW</a>) VA-domiciled companies.</li><li>Approvals are still necessary from the U.S. Committee on Foreign Investment and other regulatory bodies here and in China.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16941645-virginia-regulator-approves-proposed-oceanwide-acquisition-genworths-virginia-domiciled\" target=\"_blank\">Press Release</a></li><li>Shares&nbsp;<font color='green'>+8.8%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3295625\" data-linked=\"Genworth +8.8% as Virginia approves sale\" data-tweet=\"$GNW - Genworth +8.8% as Virginia approves sale https://seekingalpha.com/news/3295625-genworthplus-8_8-virginia-approves-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3295625-genworthplus-8_8-virginia-approves-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295613\" data-ts=\"1505422832\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCLR\" target=\"_blank\">OCLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295613-oclaroplus-1_8-raymond-james-starts-strong-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oclaro +1.8% as Raymond James starts at Strong Buy</a></h4><ul>   <li>Oclaro (<a href=\"http://seekingalpha.com/symbol/OCLR\" target=\"_blank\">OCLR</a> <font color='red'>-2%</font>) is moving up postmarket, <font color='green'>+1.8%</font>, after being initiated at Strong Buy at Raymond James.</li>    <li>The firm joins nearly a dozen other bullish Buy ratings for the optical equipment maker.</li>    <li>Raymond James has set a price target of $12, implying 36.8% upside from today's close. Shares fell to $8.77 today but are making up much of that ground in after-hours quotes, at $8.93.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3295613\" data-linked=\"Oclaro +1.8% as Raymond James starts at Strong Buy\" data-tweet=\"$OCLR - Oclaro +1.8% as Raymond James starts at Strong Buy https://seekingalpha.com/news/3295613-oclaroplus-1_8-raymond-james-starts-strong-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3295613-oclaroplus-1_8-raymond-james-starts-strong-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295602\" data-ts=\"1505422319\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMUS\" target=\"_blank\">TMUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295602-t-mobile-cfo-start-buybacks-in-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T-Mobile CFO: Could start buybacks in 2018</a></h4><ul>   <li>As T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color='red'>-2.6%</font>) looks to potential uses of its cash, it looks like <a href=\"http://www.investors.com/news/technology/t-mobile-stock-buyback-possible-in-2018-says-cfo\" target=\"_blank\">buybacks might win out over a dividend</a>, according to Chief Financial Officer Braxton Carter.</li>    <li>Speaking at Goldman Sachs Communacopia, Carter says a repurchase could come as soon as next year, but \"It's more near term than long term.\"</li>    <li>A survey of T-Mobile investors didn't find much traction for an earlier idea to start paying a small dividend, he says: \"We think we're undervalued, and a buyback might be the best use of cash.\"</li>    <li>The growing cash flow also relieves pressure T-Mobile might have felt to merge with Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color='red'>-1.3%</font>), analysts say.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3295602\" data-linked=\"T-Mobile CFO: Could start buybacks in 2018\" data-tweet=\"$TMUS $TMUS $S - T-Mobile CFO: Could start buybacks in 2018 https://seekingalpha.com/news/3295602-t-mobile-cfo-start-buybacks-in-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3295602-t-mobile-cfo-start-buybacks-in-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295598\" data-ts=\"1505421920\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTOO\" target=\"_blank\">TTOO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295598-t2-biosystems-readies-equity-offering-shares-down-20-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T2 Biosystems readies equity offering; shares down 20% after hours</a></h4><ul><li>T2 Biosystems (NASDAQ:<a href='https://seekingalpha.com/symbol/TTOO' title='T2 Biosystems'>TTOO</a>) slumps&nbsp;<font color='red'>20%</font>&nbsp;after hours in response to its <a href=\"https://seekingalpha.com/pr/16941616-t2-biosystems-announces-proposed-public-offering-common-stock\" target=\"_blank\">announcement </a>of a public offering of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3295598\" data-linked=\"T2 Biosystems readies equity offering; shares down 20% after hours\" data-tweet=\"$TTOO - T2 Biosystems readies equity offering; shares down 20% after hours https://seekingalpha.com/news/3295598-t2-biosystems-readies-equity-offering-shares-down-20-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3295598-t2-biosystems-readies-equity-offering-shares-down-20-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295595\" data-ts=\"1505421618\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNXP\" target=\"_blank\">TNXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295595-tonix-pharma-awarded-european-patent-covering-tonmya-shares-ahead-9-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tonix Pharma awarded European patent covering Tonmya; shares ahead 9% after hours</a></h4><ul><li>Thinly traded nano cap Tonix Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) is up&nbsp;<font color='green'>9%</font>&nbsp;after hours on very light volume on the heels of its <a href=\"https://seekingalpha.com/pr/16941600-tonix-pharmaceuticals-receives-european-patent-active-ingredient-tonmya-cyclobenzaprine-hcl\" target=\"_blank\">announcement </a>that the European Patent Office has issued a \"methods and compositions\" patent protecting PTSD med Tonmya (cyclobenzaprine HCl sublingual tablets). The patent is in effect until November 2030.</li></ul><div class=\"tiny-share-widget\" data-id=\"3295595\" data-linked=\"Tonix Pharma awarded European patent covering Tonmya; shares ahead 9% after hours\" data-tweet=\"$TNXP - Tonix Pharma awarded European patent covering Tonmya; shares ahead 9% after hours https://seekingalpha.com/news/3295595-tonix-pharma-awarded-european-patent-covering-tonmya-shares-ahead-9-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3295595-tonix-pharma-awarded-european-patent-covering-tonmya-shares-ahead-9-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295593\" data-ts=\"1505421476\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPTH\" target=\"_blank\">LPTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295593-lightpath-technologies-beats-0_21-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LightPath Technologies beats by $0.21, beats on revenue</a></h4><ul><li>LightPath Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/LPTH' title='LightPath Technologies, Inc.'>LPTH</a>): Q4 EPS of $0.24 <font color='green'>beats by $0.21</font>.</li><li>Revenue of $9M (+90.3% Y/Y) <font color='green'>beats by $0.25M</font>.</li><li>Shares <font color='green'>+9%</font>.</li><li><a href='https://www.sec.gov/Archives/edgar/data/889971/000165495417008467/lpth_ex991.htm'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3295593\" data-linked=\"LightPath Technologies beats by $0.21, beats on revenue\" data-tweet=\"$LPTH - LightPath Technologies beats by $0.21, beats on revenue https://seekingalpha.com/news/3295593-lightpath-technologies-beats-0_21-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3295593-lightpath-technologies-beats-0_21-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295592\" data-ts=\"1505421467\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INBK\" target=\"_blank\">INBK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295592-capital-raise-first-internet-bancorp-shares-down-1_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Capital raise at First Internet Bancorp; shares down 1.6%</a></h4><ul><li>The company is offering $40M of common stock, with underwriter KBW to be granted a greenshoe option for up to 15% of the shares sold.</li><li><a href='https://seekingalpha.com/symbol/INBK' title='First Internet Bancorp'>INBK</a>&nbsp;<font color='red'>-1.6%</font>&nbsp;after hours</li><li>Source: <a href=\"https://seekingalpha.com/pr/16941628-first-internet-bancorp-announces-commencement-common-stock-offering\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3295592\" data-linked=\"Capital raise at First Internet Bancorp; shares down 1.6%\" data-tweet=\"$INBK - Capital raise at First Internet Bancorp; shares down 1.6% https://seekingalpha.com/news/3295592-capital-raise-first-internet-bancorp-shares-down-1_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3295592-capital-raise-first-internet-bancorp-shares-down-1_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295585\" data-ts=\"1505420769\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRNS\" target=\"_blank\">MRNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295585-marinus-pharma-readies-equity-offering-shares-slip-9-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marinus Pharma readies equity offering; shares slip 9% after hours</a></h4><ul><li>Marinus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a>) is down&nbsp;<font color='red'>9%</font>&nbsp;after hours on average volume on the heels of its planned <a href=\"https://seekingalpha.com/pr/16941584-marinus-pharmaceuticals-announces-public-offering-common-stock\" target=\"_blank\">public offering</a> of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3295585\" data-linked=\"Marinus Pharma readies equity offering; shares slip 9% after hours\" data-tweet=\"$MRNS - Marinus Pharma readies equity offering; shares slip 9% after hours https://seekingalpha.com/news/3295585-marinus-pharma-readies-equity-offering-shares-slip-9-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3295585-marinus-pharma-readies-equity-offering-shares-slip-9-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295584\" data-ts=\"1505420755\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORCL\" target=\"_blank\">ORCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295584-oracle-up-after-q1-beats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oracle up after Q1 beats</a></h4><ul><li>Oracle (NYSE:<a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a>)&nbsp;<font color='green'>up 1.72%</font>&nbsp;aftermarket following Q1 EPS and revenue beats.</li><li>Segment revenue: Cloud plus On-Premise Software, $7.4B (+9% Y/Y); Cloud SaaS, $1.1B (+62%); Cloud PaaS plus IaaS, $400M (+28%); New software licenses, $966M (-6%); Software license updates and product support, $4.95B (+3%); Hardware revenue, $943M (-5%); Services, $860M (6%).</li><li>Short-term deferred revenue was up 9% on the year to $10.3B. Operating cash flow TTM was up 8% to $14.8B. The company ended the quarter with $21.3B in cash and equivalents.</li><li>Quarterly cash dividend of $0.19 per share declared payable to stockholders of record by October 11 and payable on October 25.</li><li><a href=\"https://seekingalpha.com/pr/16941583-q1-fy18-gaap-eps-19-percent-0_52-non-gaap-eps-12-percent-0_62\" target=\"_blank\">Press release</a></li><li>Will update with guidance information when available.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3295557-oracle-beats-0_02-beats-revenue\" target=\"_blank\">Oracle beats by $0.02, beats on revenue</a> (Sept. 14)</li><li>Update:&nbsp;                  Q2 guidance has revenue expected up 2% to 4% on the year, which would make the range $9.25B to $9.4B. Street consensus puts revenue at $9.49B. EPS expected between $0.64 and $0.68 at constant currency compared to the $0.68 consensus.&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3295584\" data-linked=\"Oracle up after Q1 beats\" data-tweet=\"$ORCL - Oracle up after Q1 beats https://seekingalpha.com/news/3295584-oracle-up-after-q1-beats?source=tweet\" data-url=\"https://seekingalpha.com/news/3295584-oracle-up-after-q1-beats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295582\" data-ts=\"1505420597\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOLD\" target=\"_blank\">FOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295582-amicus-galafold-okd-in-canada-shares-up-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amicus&#39; Galafold OK&#39;d in Canada; shares up 2% after hours</a></h4><ul><li>Amicus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/FOLD' title='Amicus Therapeutics, Inc.'>FOLD</a>) is up&nbsp;<font color='green'>2%</font>&nbsp;after hours on average volume in response to its <a href=\"https://seekingalpha.com/pr/16941586-amicus-therapeutics-announces-approval-galafold-migalastat-treatment-fabry-disease-canada\" target=\"_blank\">announcement </a>that Health Canada has approved Galafold (migalastat) for the treatment of Fabry disease.</li><li>The company says the product will be available to patients in the coming weeks.</li></ul><div class=\"tiny-share-widget\" data-id=\"3295582\" data-linked=\"Amicus&#39; Galafold OK&#39;d in Canada; shares up 2% after hours\" data-tweet=\"$FOLD - Amicus&#39; Galafold OK&#39;d in Canada; shares up 2% after hours https://seekingalpha.com/news/3295582-amicus-galafold-okd-in-canada-shares-up-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3295582-amicus-galafold-okd-in-canada-shares-up-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295554\" data-ts=\"1505418897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DIS\" target=\"_blank\">DIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295554-cbs-attacking-showtime-churn-plans-nfl-renewal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CBS attacking Showtime churn; plans NFL renewal</a></h4><ul>   <li>Among other comments at an investor conference today (after earlier laying out <a href=\"https://seekingalpha.com/news/3295436-cbs-takes-aim-disney-plans-streaming-sports\" target=\"_blank\">plans for a streaming sports network</a>), CBS chief Les Moonves added that Showtime has changed up its release schedule to minimize churn, and that it plans to renew its deal with the NFL.</li>    <li>Showtime now makes a <a href=\"https://www.reuters.com/article/us-cbs-corp-presentation/showtime-is-putting-out-more-shows-to-keep-online-churn-low-cbs-ceo-idUSKCN1BP1YG\" target=\"_blank\">new show every 3-4 weeks</a> in order to keep viewers tuned in, he says.</li>    <li>Moonves says that combined subscribership for its CBS All Access service and Showtime streaming would crest 4M by the end of the year.</li>    <li>Meanwhile, Bloomberg analyst Paul Sweeney says that a decline in CBS (<a href=\"http://seekingalpha.com/symbol/CBS\" target=\"_blank\">CBS</a> <font color='red'>-3.9%</font>) as well as other media names (<a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a> <font color='red'>-0.9%</font>; <a href='https://seekingalpha.com/symbol/SBGI' title='Sinclair Broadcast Group, Inc.'>SBGI</a> <font color='red'>-5.1%</font>; <a href='https://seekingalpha.com/symbol/GTN' title='Gray Television, Inc.'>GTN</a> <font color='red'>-4.5%</font>; <a href='https://seekingalpha.com/symbol/NXST' title='Nexstar Media Group, Inc.'>NXST</a> <font color='red'>-3.2%</font>) is attributable generally to Verizon commentary that it's <a href=\"https://seekingalpha.com/news/3295540-verizons-mcadam-cable-tie-dividend-safe-cost-cuts\" target=\"_blank\">moving past plans</a> to merge with telecom/media firms (well, except for <a href=\"https://seekingalpha.com/news/3295309-verizon-six-month-window-figure-online-tv-entry\" target=\"_blank\">partnering on streaming</a>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3295554\" data-linked=\"CBS attacking Showtime churn; plans NFL renewal\" data-tweet=\"$DIS $DIS $SBGI - CBS attacking Showtime churn; plans NFL renewal https://seekingalpha.com/news/3295554-cbs-attacking-showtime-churn-plans-nfl-renewal?source=tweet\" data-url=\"https://seekingalpha.com/news/3295554-cbs-attacking-showtime-churn-plans-nfl-renewal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295553\" data-ts=\"1505418778\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KR\" target=\"_blank\">KR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295553-morgan-stanley-forecasts-explosive-whole-foods-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley forecasts explosive Whole Foods growth</a></h4><ul><li>Morgan Stanley analyst Brian Nowak <a href=\"http://www.barrons.com/articles/kroger-um-this-could-be-a-problem-1505418026\" target=\"_blank\">forecasts</a> that Whole Foods can attract 25.2M customers by 2020. That mark is more than double the 12.5M customers Whole Foods had in 2016.</li><li>Today's weakness in Kroger (<a href='https://seekingalpha.com/symbol/KR' title='Kroger Co.'>KR</a> <font color='red'>-2.2%</font>), Supervalu (<a href='https://seekingalpha.com/symbol/SVU' title='SUPERVALU Inc.'>SVU</a> <font color='red'>-2.6%</font>), Natural Grocers by Vitamin Cottage (<a href='https://seekingalpha.com/symbol/NGVC' title='Natural Grocers'>NGVC</a> <font color='red'>-2.3%</font>) and Weis Markets (<a href='https://seekingalpha.com/symbol/WMK' title='Weis Markets Inc'>WMK</a> <font color='red'>-1.7%</font>) could have something to do with the MS forecast on the pace of growth at Whole Foods.</li></ul><div class=\"tiny-share-widget\" data-id=\"3295553\" data-linked=\"Morgan Stanley forecasts explosive Whole Foods growth\" data-tweet=\"$KR $KR $SVU - Morgan Stanley forecasts explosive Whole Foods growth https://seekingalpha.com/news/3295553-morgan-stanley-forecasts-explosive-whole-foods-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3295553-morgan-stanley-forecasts-explosive-whole-foods-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295551\" data-ts=\"1505418366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPG\" target=\"_blank\">SPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295551-reits-bounce-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">REITs bounce higher</a></h4><ul><li>The broad equity REIT sector had been on nice run for most of the summer, perhaps benefitting as long-term rates surprised everyone (again), and headed nicely lower. They gave back some ground this week as the 10-year Treasury yield jumped nearly 20 basis points, and markets again started to price in one more Fed rate hike this year.</li><li>Today, though, the <a href='https://seekingalpha.com/symbol/IYR' title='iShares U.S. Real Estate ETF'>IYR</a> is&nbsp;<font color='green'>up 0.55%</font>&nbsp;and <a href='https://seekingalpha.com/symbol/VNQ' title='Vanguard Real Estate ETF'>VNQ</a>&nbsp;<font color='green'>0.75%</font>, while the S&amp;P 500 posts a modest loss.</li><li>Mall and shopping center names: Simon Property (<a href='https://seekingalpha.com/symbol/SPG' title='Simon Property Group, Inc.'>SPG</a> <font color='green'>+2%</font>), Macerich (<a href='https://seekingalpha.com/symbol/MAC' title='Macerich Co.'>MAC</a> <font color='green'>+2.6%</font>), Kimco (<a href='https://seekingalpha.com/symbol/KIM' title='Kimco Realty Corporation'>KIM</a> <font color='green'>+2.9%</font>), Taubman (<a href='https://seekingalpha.com/symbol/TCO' title='Taubman Centers, Inc.'>TCO</a> <font color='green'>+1.1%</font>), DDR (DDR <font color='green'>+2.7%</font>)</li><li>Self-storage: Public Storage (<a href='https://seekingalpha.com/symbol/PSA' title='Public Storage'>PSA</a> <font color='green'>+1.9%</font>), CubeSmart (<a href='https://seekingalpha.com/symbol/CUBE' title='CubeSmart Common Shares'>CUBE</a> <font color='green'>+1.7%</font>)</li><li>Office: Boston Properties (<a href='https://seekingalpha.com/symbol/BXP' title='Boston Properties, Inc.'>BXP</a> <font color='green'>+1.8%</font>), Kilroy (<a href='https://seekingalpha.com/symbol/KRC' title='Kilroy Realty Corporation'>KRC</a> <font color='green'>+2.4%</font>), Paramount Group (<a href='https://seekingalpha.com/symbol/PGRE' title='Paramount Group'>PGRE</a> <font color='green'>+1.6%</font>)</li><li>Underperforming are the hotel names: Sunstone (<a href='https://seekingalpha.com/symbol/SHO' title='Sunstone Hotel Investors, Inc.'>SHO</a> <font color='red'>-1.7%</font>), LaSalle (<a href='https://seekingalpha.com/symbol/LHO' title='LaSalle Hotel Properties'>LHO</a> <font color='red'>-1%</font>), Chesapeake (<a href='https://seekingalpha.com/symbol/CHSP' title='Chesapeake Lodging Trust'>CHSP</a> <font color='red'>-1.6%</font>), Pebblebrook (<a href='https://seekingalpha.com/symbol/PEB' title='Pebblebrook Hotel Trust'>PEB</a> <font color='red'>-1%</font>)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/VNQ' title='Vanguard Real Estate ETF'>VNQ</a>, <a href='https://seekingalpha.com/symbol/IYR' title='iShares U.S. Real Estate ETF'>IYR</a>, <a href='https://seekingalpha.com/symbol/RQI' title='Cohen&Steers Quality Income Realty Fund'>RQI</a>, <a href='https://seekingalpha.com/symbol/SCHH' title='Schwab U.S. REIT ETF'>SCHH</a>, <a href='https://seekingalpha.com/symbol/DRN' title='Direxion Daily Real Estate Bull 3x Shares ETF'>DRN</a>, <a href='https://seekingalpha.com/symbol/RNP' title='Cohen&Steers REIT&Preferred Income Fund'>RNP</a>, <a href='https://seekingalpha.com/symbol/RFI' title='Cohen&Steers Total Return Realty Fund'>RFI</a>, <a href='https://seekingalpha.com/symbol/URE' title='ProShares Ultra Real Estate ETF'>URE</a>, <a href='https://seekingalpha.com/symbol/KBWY' title='Invesco KBW Premium Yield Equity REIT Portfolio ETF'>KBWY</a>, <a href='https://seekingalpha.com/symbol/ICF' title='iShares Cohen & Steers REIT ETF'>ICF</a>, <a href='https://seekingalpha.com/symbol/RWR' title='SPDR Dow Jones REIT ETF'>RWR</a>, <a href='https://seekingalpha.com/symbol/NRO' title='Neuberger Berman Real Estate Securities Income Fund'>NRO</a>, <a href='https://seekingalpha.com/symbol/SRS' title='ProShares UltraShort Real Estate ETF'>SRS</a>, <a href='https://seekingalpha.com/symbol/JRS' title='Nuveen Real Estate Income Fund'>JRS</a>, <a href='https://seekingalpha.com/symbol/XLRE' title='Real Estate Select Sector SPDR ETF'>XLRE</a>, <a href='https://seekingalpha.com/symbol/DRA' title='Diversified Real Asset Income Fund'>DRA</a>, <a href='https://seekingalpha.com/symbol/DRV' title='Direxion Daily Real Estate Bear 3x Shares ETF'>DRV</a>, <a href='https://seekingalpha.com/symbol/FREL' title='Fidelity MSCI Real Estate Index ETF'>FREL</a>, <a href='https://seekingalpha.com/symbol/RIF' title='RMR Real Estate Income Fund'>RIF</a>, <a href='https://seekingalpha.com/symbol/RIT' title='LMP Real Estate Income Fund'>RIT</a>, <a href='https://seekingalpha.com/symbol/LRET' title='ETRACS Monthly Pay 2xLeveraged MSCI US REIT Index ETN'>LRET</a>, <a href='https://seekingalpha.com/symbol/REK' title='ProShares Short Real Estate ETF'>REK</a>, <a href='https://seekingalpha.com/symbol/FRI' title='First Trust S&P REIT Index ETF'>FRI</a>, <a href='https://seekingalpha.com/symbol/FTY' title='iShares Real Estate 50 ETF'>FTY</a>, <a href='https://seekingalpha.com/symbol/PSR' title='Inv Act Man Exg Shs'>PSR</a>, <a href='https://seekingalpha.com/symbol/WREI' title='Invesco Wilshire U.S. Real Estate Investment Trust ETF'>WREI</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3295551\" data-linked=\"REITs bounce higher\" data-tweet=\"$SPG $IYR $VNQ - REITs bounce higher https://seekingalpha.com/news/3295551-reits-bounce-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3295551-reits-bounce-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295540\" data-ts=\"1505415965\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VZ\" target=\"_blank\">VZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295540-verizons-mcadam-no-cable-tie-up-dividend-safe-cost-cuts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Verizon&#39;s McAdam: No cable tie-up; dividend safe with cost cuts</a></h4><ul>     <li>In a wide range of discussions, Verizon (<a href=\"http://seekingalpha.com/symbol/VZ\" target=\"_blank\">VZ</a> <font color=\"red\">-0.3%</font>) chief Lowell McAdam makes the point that the company has moved on from cable tie-ups (to focus instead on fiber/5G) and that it will be able to keep up its dividend by managing costs.</li>     <li>Rumors have linked Verizon to mergers with any number of media companies but also top telecoms like Comcast (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color=\"red\">-0.7%</font>) and Charter (<a href=\"http://seekingalpha.com/symbol/CHTR\" target=\"_blank\">CHTR</a> <font color=\"red\">-1.7%</font>), but <a href=\"http://www.bloomberg.com/news/articles/2017-09-14/it-s-official-verizon-has-moved-on-from-possible-cable-tie-up\" target=\"_blank\">Verizon has \"moved on,\"</a> he says.</li>     <li>One complicating factor may have been Comcast and Charter's <a href=\"https://seekingalpha.com/news/3264525-comcast-charter-form-wireless-alliance\" target=\"_blank\">deal to work together</a> on an entry into wireless communications. But McAdam argued it would focus on fiber and 5G deployment rather than getting into bed with a company that had a huge coaxial network that would need to be reconfigured or replaced.</li>     <li>As for AT&amp;T (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color=\"red\">-0.8%</font>) and T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color=\"red\">-2%</font>) offering HBO and Netflix for free, McAdam <a href=\"https://www.cnbc.com/2017/09/14/verizons-lowell-mcadam-next-generation-5g-is4th-industrial-revolution.html\" target=\"_blank\">isn't worried</a>, saying Verizon could make a deal like that anytime and that consumers will care more about reliable networking than freebies: \"At the end of the day, customers will buy based on their experience, doing what they need to do, not whether they have Netflix or not.\"</li>     <li>The company will plan to cut $10B in costs by 2022 and largely <a href=\"http://www.investors.com/news/technology/verizon-aims-to-slash-10-billion-in-costs-to-fund-dividend\" target=\"_blank\">pay its dividend with those savings</a>, he's said.</li>     <li>Yesterday, he said it's \"critical\" that the carrier unveil its <a href=\"https://seekingalpha.com/news/3295309-verizon-six-month-window-figure-online-tv-entry\" target=\"_blank\">own over-the-top TV service</a> and that it had about six months to decide how to do it.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3295540\" data-linked=\"Verizon&#39;s McAdam: No cable tie-up; dividend safe with cost cuts\" data-tweet=\"$VZ $VZ $CMCSA - Verizon&#39;s McAdam: No cable tie-up; dividend safe with cost cuts https://seekingalpha.com/news/3295540-verizons-mcadam-no-cable-tie-up-dividend-safe-cost-cuts?source=tweet\" data-url=\"https://seekingalpha.com/news/3295540-verizons-mcadam-no-cable-tie-up-dividend-safe-cost-cuts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295537\" data-ts=\"1505415626\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295537-technology-top-gainers-losers-of-3_00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3.00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FENG' title='Phoenix New Media Limited'>FENG</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/CSOD' title='Cornerstone OnDemand, Inc.'>CSOD</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/RFIL' title='RF Industries, Ltd.'>RFIL</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/GRVY' title='GRAVITY Co., Ltd. - American depositary shares, each representing one'>GRVY</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/OPNT' title='Opiant Pharmaceuticals, Inc.'>OPNT</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CRTO' title='Criteo S.A.'>CRTO</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3295537\" data-linked=\"Technology - Top Gainers / Losers as of 3.00 pm\" data-tweet=\"$FENG $VERI $CSOD - Technology - Top Gainers / Losers as of 3.00 pm https://seekingalpha.com/news/3295537-technology-top-gainers-losers-of-3_00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3295537-technology-top-gainers-losers-of-3_00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295532\" data-ts=\"1505414295\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLO\" target=\"_blank\">VLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295532-valero-underestimated-benzene-leak-houston-refinery-epa-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valero underestimated benzene leak at Houston refinery, EPA says</a></h4><ul>     <li>Valero Energy (<a href='https://seekingalpha.com/symbol/VLO' title='Valero Energy Corporation'>VLO</a> <font color='red'>-1.6%</font>) \"<a href=\"http://www.chron.com/business/energy/article/Valero-significantly-underestimated-benzene-12198006.php\" target=\"_blank\">significantly underestimated</a>\" the amount of cancer-causing benzene and other toxic compounds leaked from its Houston refinery during Hurricane Harvey, the EPA says.</li>     <li>VLO had reported that the leak from a partially collapsed roof of a storage tank released an estimated 6.7 lbs. of benzene and more than 3,350 lbs. of unspecified volatile compounds, but the EPA says VLO now is preparing a new report that will show a substantial increase in emissions from the incident.</li><li>The <a href=\"https://seekingalpha.com/news/3293699-benzene-detected-houston-area-valero-hurricane-related-leak\" target=\"_blank\">benzene release</a> by the VLO refinery was the strongest  concentration of toxic compounds detected by any independent air  monitoring throughout the Houston area in Harvey's aftermath.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3295532\" data-linked=\"Valero underestimated benzene leak at Houston refinery, EPA says\" data-tweet=\"$VLO - Valero underestimated benzene leak at Houston refinery, EPA says https://seekingalpha.com/news/3295532-valero-underestimated-benzene-leak-houston-refinery-epa-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3295532-valero-underestimated-benzene-leak-houston-refinery-epa-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295528\" data-ts=\"1505412759\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HUSA\" target=\"_blank\">HUSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295528-houston-american-energyplus-17-after-drilling-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Houston American Energy +17% after drilling update</a></h4><ul>     <li>Houston American Energy (<a href='https://seekingalpha.com/symbol/HUSA' title='Houston American Energy Corp.'>HUSA</a> <font color='green'>+17.7%</font>) jumps after providing an <a href=\"https://seekingalpha.com/pr/16941383-houston-american-energy-announces-initial-production-rate-obrien-3h-well-provides-update\" target=\"_blank\">update to planned operations</a> in Reeves County, Tex., including initial production information on its O'Brien #3H well.</li>     <li>HUSA says a recent flowback report from the field indicated a daily production rate of 1,039 boe/day.</li>     <li>HUSA believes the well and the recently completed Johnson State #1H well will be brought to production upon completion of construction of gas flow lines, which is expected this month.</li></ul><div class=\"tiny-share-widget\" data-id=\"3295528\" data-linked=\"Houston American Energy +17% after drilling update\" data-tweet=\"$HUSA - Houston American Energy +17% after drilling update https://seekingalpha.com/news/3295528-houston-american-energyplus-17-after-drilling-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3295528-houston-american-energyplus-17-after-drilling-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295526\" data-ts=\"1505412075\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295526-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/WTI' title='W&T Offshore, Inc.'>WTI</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/JONE' title='Jones Energy, Inc.'>OTC:JONE</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/SNES' title='SenesTech'>SNES</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/DNR' title='Denbury Resources Inc.'>DNR</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/CGG-OLD' title='CGG'>CGG-OLD</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ESES' title='Eco-Stim Energy Solutions, Inc.'>ESES</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/YUMA' title='Yuma Energy, Inc.'>YUMA</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ERN' title='Erin Energy Corp.'>ERN</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3295526\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$WTI $JONE $SNES - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3295526-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3295526-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295524\" data-ts=\"1505411736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSOD\" target=\"_blank\">CSOD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295524-bloomberg-cornerstone-ondemand-hires-advisers-shares-up-12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Cornerstone OnDemand hires advisers; shares up 12%</a></h4><ul><li>Cornerstone OnDemand (<a href='https://seekingalpha.com/symbol/CSOD' title='Cornerstone OnDemand, Inc.'>CSOD</a> <font color='green'>+12%</font>) has hired Centerview Partners and Goldman Sachs to help with a strategic review, reports Bloomberg.</li><li>The advisers are pitching the company to potential suitors as well as helping defend against activist investor&nbsp;Praesidium.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3229857-cornerstone-ondemand-mulls-selling\" target=\"_blank\">Cornerstone OnDemand mulls selling itself</a> (Dec. 10, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3295524\" data-linked=\"Bloomberg: Cornerstone OnDemand hires advisers; shares up 12%\" data-tweet=\"$CSOD - Bloomberg: Cornerstone OnDemand hires advisers; shares up 12% https://seekingalpha.com/news/3295524-bloomberg-cornerstone-ondemand-hires-advisers-shares-up-12?source=tweet\" data-url=\"https://seekingalpha.com/news/3295524-bloomberg-cornerstone-ondemand-hires-advisers-shares-up-12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295520\" data-ts=\"1505410759\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NYMX\" target=\"_blank\">NYMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295520-nymoxs-marketing-application-in-europe-for-bph-med-fexapotide-triflutate-accepted-for-review\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nymox&#39;s marketing application in Europe for BPH med fexapotide triflutate accepted for review; shares ahead 8%</a></h4><ul><li>Thinly traded micro cap Nymox Pharmaceutical (<a href='https://seekingalpha.com/symbol/NYMX' title='Nymox Pharmaceutical Corporation'>NYMX</a> <font color='green'>+8.4%</font>) perks up on triple normal volume, albeit on turnover of only 341K shares, in response to its <a href=\"https://seekingalpha.com/pr/16941364-nymox-application-validated\" target=\"_blank\">announcement </a>that its marketing application seeking approval for fexapotide triflutate for the treatment of benign prostatic hyperplasia &#40;BPH&#41;, commonly known as an enlarged prostate, has been accepted for review in Europe.</li><li><a href=\"http://www.nymox.com/default.action?itemid=23\" target=\"_blank\">Fexapotide&nbsp;</a>(NX-1207)&nbsp;is administered directly into the prostate via a transrectal injection that does not require anesthesia or sedation.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3213384-long-term-data-positive-nymoxs-bph-candidate-fexapotide-shares-17-percent\" target=\"_blank\">Long-term data positive for Nymox's BPH candidate fexapotide; shares up 17%</a> (Oct. 11, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3295520\" data-linked=\"Nymox&#39;s marketing application in Europe for BPH med fexapotide triflutate accepted for review; shares ahead 8%\" data-tweet=\"$NYMX - Nymox&#39;s marketing application in Europe for BPH med fexapotide triflutate accepted for review; shares ahead 8% https://seekingalpha.com/news/3295520-nymoxs-marketing-application-in-europe-for-bph-med-fexapotide-triflutate-accepted-for-review?source=tweet\" data-url=\"https://seekingalpha.com/news/3295520-nymoxs-marketing-application-in-europe-for-bph-med-fexapotide-triflutate-accepted-for-review\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295521\" data-ts=\"1505410583\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNMA\" target=\"_blank\">FNMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295521-capital-buffer-chatter-sends-gses-sharply-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Capital buffer chatter sends GSEs sharply higher</a></h4><ul><li>The move began late yesterday afternoon after six Senate Democrats called on the FHFA and Treasury to let Fannie Mae (<a href='https://seekingalpha.com/symbol/FNMA' title='Fannie Mae'>OTCQB:FNMA</a> <font color='green'>+13.5%</font>) and Freddie Mac (<a href='https://seekingalpha.com/symbol/FMCC' title='Freddie Mac'>OTCQB:FMCC</a> <font color='green'>+13.3%</font>) begin to build capital.</li><li>This morning, Cowen's Jaret Seiberg said he could see the FHFA either allowing a small capital cushion or changing when it collects dividends from the two. He's not expecting quick action from yesterday's letter, noting some powerful names who didn't sign: Sanders, Warren Schumer, Durbin</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3295521\" data-linked=\"Capital buffer chatter sends GSEs sharply higher\" data-tweet=\"$FNMA $FNMA $FMCC - Capital buffer chatter sends GSEs sharply higher https://seekingalpha.com/news/3295521-capital-buffer-chatter-sends-gses-sharply-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3295521-capital-buffer-chatter-sends-gses-sharply-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>106&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295516\" data-ts=\"1505410298\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATOS\" target=\"_blank\">ATOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295516-atossas-topical-breast-cancer-candidate-endoxifen-performs-well-in-early-stage-study-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atossa&#39;s topical breast cancer candidate endoxifen performs well in early-stage study; shares ahead 21%</a></h4><ul><li>Nano cap Atossa Genetics (<a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics, Inc.'>ATOS</a> <font color='green'>+21.1%</font>) jumps on a more than a 6x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/16941394-atossa-genetics-announces-preliminary-results-phase-1-study-topical-endoxifen\" target=\"_blank\">announcement </a>of positive results in a 48-subject Phase 1 dose escalation study of topical endoxifen. All objectives were achieved.</li><li>No safety signals were observed and endoxifen was well-tolerated at each dose level. It demonstrated that it crossed the skin barrier when applied daily to the breast in a dose-dependent way.</li><li>The company will release data from the oral arm in the next 30-60 days.</li><li>Endoxifen is an active metabolite of tamoxifen, the active ingredient in AstraZeneca's Nolvadex (the company stopped making it in June 2006).</li><li>Development is ongoing.</li></ul><div class=\"tiny-share-widget\" data-id=\"3295516\" data-linked=\"Atossa&#39;s topical breast cancer candidate endoxifen performs well in early-stage study; shares ahead 21%\" data-tweet=\"$ATOS - Atossa&#39;s topical breast cancer candidate endoxifen performs well in early-stage study; shares ahead 21% https://seekingalpha.com/news/3295516-atossas-topical-breast-cancer-candidate-endoxifen-performs-well-in-early-stage-study-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3295516-atossas-topical-breast-cancer-candidate-endoxifen-performs-well-in-early-stage-study-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295515\" data-ts=\"1505409513\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295515-boeing-surges-near-all-time-high-after-planned-787-production-pickup\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing surges near all-time high after planned 787 production pickup</a></h4><ul>     <li>Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color='green'>+1.3%</font>)&nbsp;is easily today's biggest Dow gainer after Wednesday's <a href=\"https://seekingalpha.com/news/3295206-boeing-move-ceo-presents\" target=\"_blank\">upbeat presentation</a>, as CEO Dennis Muilenburg told surprised analysts the company was increasing production of its flagship 787 Dreamliner from 12 per month to 14 by 2019.</li>     <li>Cowen's Cai von Rumohr, who rates BA at Outperform with a $300 price target, <a href=\"http://www.barrons.com/articles/boeing-breakout-1505402786\" target=\"_blank\">raises his earnings estimates</a>: \"Because the block extension increases the number of 787's still to be delivered by 14%, we estimate that it could add 4%-5% to the program's profit accrual rate and $0.15-$0.20 to 2017 \"core\" EPS and $0.30-$0.40 to 2018 EPS.</li>     <li>Jefferies analyst Howard Rubel, who rates the stock a Buy with a $275 target, says assuming a cost of $145M per widebody and ~24% cash margins, revenue and profit from the 787 increase could be in the <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/09/10058188/boeings-ceo-strikes-optimistic-tone-at-analyst-conferen\" target=\"_blank\">neighborhood of $3.3B and $800M</a>, respectively, in 2020.</li>     <li>Canaccord analysts say BA's announcement could be positive for its suppliers, particularly Triumph Group (<a href='https://seekingalpha.com/symbol/TGI' title='Triumph Group, Inc.'>TGI</a> <font color='red'>-0.7%</font>) and Spirit AeroSystems (<a href='https://seekingalpha.com/symbol/SPR' title='Spirit AeroSystems Holdings, Inc.'>SPR</a> <font color='green'>+1.9%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3295515\" data-linked=\"Boeing surges near all-time high after planned 787 production pickup\" data-tweet=\"$BA $BA $TGI - Boeing surges near all-time high after planned 787 production pickup https://seekingalpha.com/news/3295515-boeing-surges-near-all-time-high-after-planned-787-production-pickup?source=tweet\" data-url=\"https://seekingalpha.com/news/3295515-boeing-surges-near-all-time-high-after-planned-787-production-pickup\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295508\" data-ts=\"1505408527\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295508-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RVEN' title='Reven Housing REIT, Inc.'>RVEN</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/NYRT' title='New York REIT'>NYRT</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3295508\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$GROW $RVEN $NYRT - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3295508-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3295508-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295505\" data-ts=\"1505407917\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STAR\" target=\"_blank\">STAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295505-istar-up-4-debt-sale-improves-liquidity-position\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">iStar up 4% as debt sale improves liquidity position</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/16940584-istar-launches-offerings-senior-unsecured-notes-senior-convertible-notes\" target=\"_blank\">The company today launched</a> an offering of $800M of senior unsecured paper due in 2020 and 2022, and a private offering of $250M of senior convertible notes due 2022.</li><li>Proceeds will be used to pay in full 4% senior notes ($550M in principal) coming due in November, 7.125% senior notes ($300M) maturing in February, 7.88% Series E preferred stock ($140M), and 7.8% Series F preferred stock ($100M).</li><li>The company is also authorized to buy back up to $50M in common stock in private deals with the convertible buyers.</li><li>Noting a materially improved liquidity position, Fitch boosts iStar's (<a href='https://seekingalpha.com/symbol/STAR' title='iStar Inc.'>STAR</a> <font color='green'>+3.8%</font>) IDR rating to BB- from B+. The outlook is cut to stable from positive.</li></ul><div class=\"tiny-share-widget\" data-id=\"3295505\" data-linked=\"iStar up 4% as debt sale improves liquidity position\" data-tweet=\"$STAR - iStar up 4% as debt sale improves liquidity position https://seekingalpha.com/news/3295505-istar-up-4-debt-sale-improves-liquidity-position?source=tweet\" data-url=\"https://seekingalpha.com/news/3295505-istar-up-4-debt-sale-improves-liquidity-position\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295503\" data-ts=\"1505407433\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295503-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PLSE' title='Pulse Biosciences'>PLSE</a> <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/CASI' title='CASI Pharmaceuticals'>CASI</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/HALO' title='Halozyme Therapeutics, Inc.'>HALO</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/PAVM' title='PAVmed Inc.'>PAVM</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/OMNT' title='Ominto, Inc.'>OTCPK:OMNT</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/WTI' title='W&T Offshore, Inc.'>WTI</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/PTIE' title='Pain Therapeutics'>PTIE</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/FENG' title='Phoenix New Media Limited'>FENG</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/OPNT' title='Opiant Pharmaceuticals, Inc.'>OPNT</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/SMMT' title='Summit Therapeutics'>SMMT</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/GKOS' title='Glaukos'>GKOS</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/BVXV' title='Biondvax Pharmaceuticals'>BVXV</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/RVEN' title='Reven Housing REIT, Inc.'>RVEN</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/SAGE' title='Sage Therapeutics'>SAGE</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3295503\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$PLSE $CASI $ALDX - Midday Gainers / Losers https://seekingalpha.com/news/3295503-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3295503-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295495\" data-ts=\"1505405997\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYNMF\" target=\"_blank\">WYNMF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295495-morgan-stanley-warns-on-unionpay-dependence-in-macau\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley warns on UnionPay dependence in Macau</a></h4><ul> <li>Morgan Stanley <a href=\"http://www.ggrasia.com/unionpay-cash-use-a-risk-to-macau-premium-mass-study/\" target=\"_blank\">calls</a> the dependence of premium mass market customers in Macau on China UnionPay cards for gambling funds a risk.</li> <li>The firm notes that as much as 70% of gambling funds in the segment are sourced through UnionPay cards vs. 60% in 2015.</li> <li>The Macau government tightened local rules on cash withdrawals earlier this year and could act again. The cards also have an annual cash withdrawal limit at overseas ATMs of just $15,290.</li>     <li>Macau casino stocks: Wynn Macau (<a href='https://seekingalpha.com/symbol/WYNMF' title='Wynn Macau Ltd.'>OTCPK:WYNMF</a>, <a href='https://seekingalpha.com/symbol/WYNMY' title='Wynn Macau Ltd. ADR'>OTCPK:WYNMY</a>, <a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>), Sands China (<a href='https://seekingalpha.com/symbol/SCHYY' title='Sands China Ltd ADR'>OTCPK:SCHYY</a>, <a href='https://seekingalpha.com/symbol/SCHYF' title='Sands China Ltd'>OTCPK:SCHYF</a>, <a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a>), MGM China (<a href='https://seekingalpha.com/symbol/MCHVF' title='MGM China Holdings, Ltd.'>OTCPK:MCHVF</a>, <a href='https://seekingalpha.com/symbol/MCHVY' title='MGM China Holdings, Ltd. ADR'>OTCPK:MCHVY</a>, <a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a>), Galaxy Entertainment (<a href='https://seekingalpha.com/symbol/GXYEF' title='Galaxy Entertainment Group, Ltd.'>OTCPK:GXYEF</a>), SJM Holdings (<a href='https://seekingalpha.com/symbol/SJMHF' title='SJM Holdings Ltd.'>OTCPK:SJMHF</a>, <a href='https://seekingalpha.com/symbol/SJMHY' title='SJM Holdings Ltd. ADR'>OTCPK:SJMHY</a>), Melco Resorts &amp; Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/MLCO' title='Melco Resorts & Entertainment Limited ADR'>MLCO</a>).</li>     <li>Related ETF: <a href='https://seekingalpha.com/symbol/BJK' title='VanEck Vectors Gaming ETF'>BJK</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3295495\" data-linked=\"Morgan Stanley warns on UnionPay dependence in Macau\" data-tweet=\"$WYNMF $WYNMF $WYNMY - Morgan Stanley warns on UnionPay dependence in Macau https://seekingalpha.com/news/3295495-morgan-stanley-warns-on-unionpay-dependence-in-macau?source=tweet\" data-url=\"https://seekingalpha.com/news/3295495-morgan-stanley-warns-on-unionpay-dependence-in-macau\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295490\" data-ts=\"1505404902\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295490-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ALV' title='Autoliv Inc.'>ALV</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/NVFY' title='Nova Lifestyle, Inc.'>NVFY</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/CLXT' title='Calyxt, Inc.'>CLXT</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/SGOC' title='SGOCO Techn'>SGOC</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/OBCI' title='Ocean Bio-Chem, Inc.'>OBCI</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3295490\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$ALV $NVFY $CLXT - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3295490-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3295490-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295488\" data-ts=\"1505404787\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMMY-OLD\" target=\"_blank\">IMMY-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295488-fda-inquiry-mislabeling-of-castor-oil-confirms-statements-imprimis-pharma-shares-ahead-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA inquiry into mislabeling of castor oil confirms statements by Imprimis Pharma; shares ahead 2%</a></h4><ul><li>Thinly traded nano cap Imprimis Pharmaceuticals (<a href='https://seekingalpha.com/symbol/IMMY-OLD' title='Imprimis Pharmaceuticals, Inc.'>IMMY-OLD</a> <font color='green'>+2.4%</font>) announces that it received a letter from the FDA on September 5 that confirmed its earlier statements that its use of non-pharmaceutical grade PEG 40 Castor Oil in its curcumin emulsion was due to mislabeling by the supplier. The company says it terminated its business relationship with the supplier after learning about the mislabeling.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3286036-imprimis-18-percent-fda-inquiry-compounded-product\" target=\"_blank\">Imprimis down 18% of FDA inquiry into compounded product</a> (Aug. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3295488\" data-linked=\"FDA inquiry into mislabeling of castor oil confirms statements by Imprimis Pharma; shares ahead 2%\" data-tweet=\"$IMMY-OLD - FDA inquiry into mislabeling of castor oil confirms statements by Imprimis Pharma; shares ahead 2% https://seekingalpha.com/news/3295488-fda-inquiry-mislabeling-of-castor-oil-confirms-statements-imprimis-pharma-shares-ahead-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3295488-fda-inquiry-mislabeling-of-castor-oil-confirms-statements-imprimis-pharma-shares-ahead-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295484\" data-ts=\"1505404010\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FBIO\" target=\"_blank\">FBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295484-mustang-bio-adds-cd20-directed-car-ts-to-pipeline-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mustang Bio adds CD20-directed CAR Ts to pipeline; shares up 1%</a></h4><ul><li>Thinly traded micro cap Mustang Bio (<a href='https://seekingalpha.com/symbol/MBIO' title='Mustang Bio, Inc.'>MBIO</a> <font color='green'>+1.1%</font>) perks up on light volume on the <a href=\"https://seekingalpha.com/pr/16940696-mustang-bio-announces-expansion-car-t-pipeline-cd20-directed-immunotherapies\" target=\"_blank\">news</a> that it has extended its pipeline of CAR T therapies into the CD20-directed arena.</li><li>The company has inked an exclusive global licensing agreement with Fred Hutchinson Cancer Research Center for the CD20 technology that includes partial funding for a Phase 1/2 study in relapsed/refractory B-cell non-Hodgkin lymphomas that will be initiated in Q4.</li><li>Financial terms are not disclosed.</li><li>Mustang is a subsidiary of Fortress Biotech (<a href='https://seekingalpha.com/symbol/FBIO' title='Fortress Biotech, Inc.'>FBIO</a> <font color='green'>+1.5%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3295484\" data-linked=\"Mustang Bio adds CD20-directed CAR Ts to pipeline; shares up 1%\" data-tweet=\"$FBIO $MBIO - Mustang Bio adds CD20-directed CAR Ts to pipeline; shares up 1% https://seekingalpha.com/news/3295484-mustang-bio-adds-cd20-directed-car-ts-to-pipeline-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3295484-mustang-bio-adds-cd20-directed-car-ts-to-pipeline-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295480\" data-ts=\"1505402608\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295480-pound-adds-to-gain-carney-talks-rate-hikes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pound adds to gain as Carney talks rate hikes</a></h4><ul><li>Speaking to the press following the Bank of England's policy meeting this morning (no change to rates, but a hawkish statement), Governor Mark Carney says rates may need to go higher in coming months.</li><li>The weak pound (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXB' title='CurrencyShares British Pound Sterling Trust ETF'>FXB</a>), he says, is helping to boost the inflation rate. This just in: Since bottoming at about $1.19 late last year, the pound has moved in a straight line higher to the current $1.3380 (<font color='green'>up 1.3% today</font>) - that's stronger than its pre-Brexit vote level.</li><li>The FTSE today is&nbsp;<font color='red'>lower by 1%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EWU' title='iShares MSCI United Kingdom ETF'>EWU</a>, <a href='https://seekingalpha.com/symbol/DBUK' title='Deutsche X-trackers MSCI United Kingdom Hedged Equity ETF'>DBUK</a>, <a href='https://seekingalpha.com/symbol/FKU' title='First Trust United Kingdom AlphaDex ETF'>FKU</a>, <a href='https://seekingalpha.com/symbol/EWUS' title='iShares MSCI United Kingdom Small Cap Index ETF'>EWUS</a>, <a href='https://seekingalpha.com/symbol/DXPS' title='WisdomTree United Kingdom Hedged Equity ETF'>DXPS</a>, <a href='https://seekingalpha.com/symbol/HEWU' title='iShares Currency Hedged MSCI United Kingdom ETF'>HEWU</a>, <a href='https://seekingalpha.com/symbol/QGBR' title='SPDR MSCI United Kingdom Quality Mix ETF'>QGBR</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3295365-bank-england-hold-pound-rallies-hint-future-rate-boost\" target=\"_blank\">Bank of England on hold; pound rallies on hint of future rate boost</a> (Sept. 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3295480\" data-linked=\"Pound adds to gain as Carney talks rate hikes\" data-tweet=\"$FXB $EWU $DBUK - Pound adds to gain as Carney talks rate hikes https://seekingalpha.com/news/3295480-pound-adds-to-gain-carney-talks-rate-hikes?source=tweet\" data-url=\"https://seekingalpha.com/news/3295480-pound-adds-to-gain-carney-talks-rate-hikes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295478\" data-ts=\"1505402579\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNRX\" target=\"_blank\">VNRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295478-volitionrx-nabs-four-new-patents-covering-nu-q-platform-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VolitionRx nabs four new patents covering Nu.Q platform; shares up 1%</a></h4><ul><li>Thinly traded nano cap VolitionRx (<a href='https://seekingalpha.com/symbol/VNRX' title='VolitionRX Ltd'>VNRX</a> <font color='green'>+1.4%</font>) perks up, albeit on miniscule volume, in response to its <a href=\"https://seekingalpha.com/pr/16940649-volition-granted-four-additional-patents\" target=\"_blank\">announcement </a>that it has been awarded four new patents (one each in the U.S., Europe, Australia and Mexico) covering its <a href=\"http://volitionrx.com/nu-q\" target=\"_blank\">Nu.Q platform</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3295478\" data-linked=\"VolitionRx nabs four new patents covering Nu.Q platform; shares up 1%\" data-tweet=\"$VNRX - VolitionRx nabs four new patents covering Nu.Q platform; shares up 1% https://seekingalpha.com/news/3295478-volitionrx-nabs-four-new-patents-covering-nu-q-platform-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3295478-volitionrx-nabs-four-new-patents-covering-nu-q-platform-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295475\" data-ts=\"1505401939\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JUNO\" target=\"_blank\">JUNO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295475-takeover-rumor-du-jour-juno-therapeutics-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Takeover rumor du jour: Juno Therapeutics; shares up 2%</a></h4><ul><li>Not really a news flash considering the Gilead/Kite tie-up, but Juno Therapeutics (<a href='https://seekingalpha.com/symbol/JUNO' title='Juno Therapeutics'>JUNO</a> <font color='green'>+1.8%</font>) is the rumored takeover candidate of the day.</li><li>Source: Briefing.com.</li></ul><div class=\"tiny-share-widget\" data-id=\"3295475\" data-linked=\"Takeover rumor du jour: Juno Therapeutics; shares up 2%\" data-tweet=\"$JUNO - Takeover rumor du jour: Juno Therapeutics; shares up 2% https://seekingalpha.com/news/3295475-takeover-rumor-du-jour-juno-therapeutics-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3295475-takeover-rumor-du-jour-juno-therapeutics-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295469\" data-ts=\"1505401361\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OBMP\" target=\"_blank\">OBMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295469-oncbiomune-cancer-vaccine-candidate-successful-in-early-stage-study-shares-up-59\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OncBioMune cancer vaccine candidate successful in early-stage study; shares up 59%</a></h4><ul><li>Thinly traded nano cap OncBioMune Pharmaceuticals (<a href='https://seekingalpha.com/symbol/OBMP' title='OncBioMune Pharmaceuticals, Inc.'>OTCPK:OBMP</a> <font color='green'>+59.1%</font>) jumps on a 6x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/16940795-oncbiomune-meets-primary-objective-trial-proscavax-immunotherapy-vaccine-prostate-cancer\" target=\"_blank\">announcement </a>of positive results in a Phase 1a clinical trial assessing cancer therapeutic vaccine candidate ProscaVax in patients with recurrent prostate cancer with increasing prostate-specific antigen &#40;PSA&#41; levels.</li><li>The study met its primary endpoint of no dose-limiting adverse events 30 days post-final vaccination in 20 patients who received a six-dose vaccination regimen. No serious adverse events were observed either.</li><li>At median follow-up of 31 months post-final dose, 64.3% (n=9/14) of evaluable patients experienced increased PSA doubling time, suggesting slower tumor growth. 80.0% (n=12/15) of patients who completed the protocol showed an increased immune response to PSA as determined by assay.</li><li>ProscaVax is a combination of prostate cancer-associated PSA, interleukin-2 (IL-2) and granulocyte-macrophage colony-stimulating factor (GM-CSF).</li><li>The company plans to advance ProscaVax into Phase 2 development.</li></ul><div class=\"tiny-share-widget\" data-id=\"3295469\" data-linked=\"OncBioMune cancer vaccine candidate successful in early-stage study; shares up 59%\" data-tweet=\"$OBMP - OncBioMune cancer vaccine candidate successful in early-stage study; shares up 59% https://seekingalpha.com/news/3295469-oncbiomune-cancer-vaccine-candidate-successful-in-early-stage-study-shares-up-59?source=tweet\" data-url=\"https://seekingalpha.com/news/3295469-oncbiomune-cancer-vaccine-candidate-successful-in-early-stage-study-shares-up-59\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295442\" data-ts=\"1505401249\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295442-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/PLSE' title='Pulse Biosciences'>PLSE</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/HALO' title='Halozyme Therapeutics, Inc.'>HALO</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/PAVM' title='PAVmed Inc.'>PAVM</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/CATB' title='Catabasis Pharmaceuticals'>CATB</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SMMT' title='Summit Therapeutics'>SMMT</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/GKOS' title='Glaukos'>GKOS</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/BVXV' title='Biondvax Pharmaceuticals'>BVXV</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/TTOO' title='T2 Biosystems'>TTOO</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3295442\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$ALDX $PLSE $HALO - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3295442-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3295442-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295465\" data-ts=\"1505399866\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EQT\" target=\"_blank\">EQT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295465-eqt-says-is-exploring-options-after-second-activist-calls-for-breakup\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EQT says it is exploring options after second activist calls for breakup</a></h4><ul>     <li>EQT Corp. (<a href='https://seekingalpha.com/symbol/EQT' title='EQT Corporation'>EQT</a> <font color='green'>+4.4%</font>) opens with strong gains after hedge fund firm D.E. Shaw sends a letter to the company's board outlining a plan it says could <a href=\"http://www.businesswire.com/news/home/20170914005484/en/D.-E.-Shaw-Group-Outlines-Detailed-Plan\" target=\"_blank\">unlock $8B of value for shareholders</a>, confirming <a href=\"https://seekingalpha.com/news/3295325-wsj-eqt-corp-pressured-second-investor-proposed-rice-takeover\" target=\"_blank\">last night's <em>WSJ</em> report</a>.</li>     <li>4% shareholder Shaw is urging the company to split into separate production and midstream units after completing its purchase of Rice Energy (<a href='https://seekingalpha.com/symbol/RICE' title='Rice Energy Inc'>RICE</a> <font color='green'>+4.4%</font>), and wants it to merge its pipeline business with the Rice Midstream Partners (<a href='https://seekingalpha.com/symbol/RMP' title='Rice Midstream Partners LP'>RMP</a> <font color='green'>+0.1%</font>) MLP.</li>     <li>In response, EQT says it will establish a committee of independent board members to <a href=\"https://www.wsj.com/articles/eqt-says-it-is-exploring-options-amid-pressure-to-split-1505393419\" target=\"_blank\">explore options</a>, will no longer use production volume as a performance metric for long-term compensation - addressing a concern that the metric has encouraged volume growth over efficiency - and will unveil a plan in Q1 2018, before its next annual meeting.</li>     <li>Both Shaw and Jana Partners are now calling for EQT to split in two but while the deal to buy Rice is opposed by Jana, Shaw says in its letter that EQT should continue with the deal and then split the businesses.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3295465\" data-linked=\"EQT says it is exploring options after second activist calls for breakup\" data-tweet=\"$EQT $EQT $RICE - EQT says it is exploring options after second activist calls for breakup https://seekingalpha.com/news/3295465-eqt-says-is-exploring-options-after-second-activist-calls-for-breakup?source=tweet\" data-url=\"https://seekingalpha.com/news/3295465-eqt-says-is-exploring-options-after-second-activist-calls-for-breakup\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295461\" data-ts=\"1505399418\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295461-natural-gas-inventory-builds-expected\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas inventory builds more than expected</a></h4><ul>     <li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory</a>: <strong>+91 Bcf</strong> vs. +85 Bcf consensus, +65 Bcf last week.</li>     <li>Futures&nbsp;<font color='red'>-0.13%</font>&nbsp;to $3.054.</li>     <li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/GAZ' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>,<a href='https://seekingalpha.com/symbol/DCNG' title='iPath Pure Beta Seasonal Natural Gas ETN'>DCNG</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3295461\" data-linked=\"Natural gas inventory builds more than expected\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas inventory builds more than expected https://seekingalpha.com/news/3295461-natural-gas-inventory-builds-expected?source=tweet\" data-url=\"https://seekingalpha.com/news/3295461-natural-gas-inventory-builds-expected\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295455\" data-ts=\"1505398439\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295455-u-s-crude-clears-50-bbl-for-first-time-in-five-weeks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. crude clears $50/bbl for first time in five weeks</a></h4><ul>     <li>U.S. crude oil <a href=\"https://www.cnbc.com/2017/09/13/oil-holds-gains-buoyed-by-hopes-for-robust-demand.html\" target=\"_blank\">hits $50/bbl for the first time in five weeks</a>, extending <a href=\"https://seekingalpha.com/news/3295203-crude-oil-shoots-higher-signs-tightening-supply\" target=\"_blank\">yesterday's strong gains</a> after forecasts for stronger oil demand by the International Energy Agency; energy stocks (<a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a> <font color='green'>+1%</font>) open strong as WTI currently <font color='green'>+1.5%</font> at $50.05/bbl after gaining 2.2% yesterday.</li>     <li>WTI popped above its 200-day moving average level of $49.55 earlier in the session, a level it had not breached on an intraday basis since Aug. 10.</li>     <li>Brent crude now <font color='green'>+0.9%</font> at $55.69/bbl for its highest since April, after rising 1.6% on Wednesday.</li><li>The gains followed an IEA report which raised its estimate of 2017 world oil  demand growth to 1.6M bbl/day from 1.5M bbl/day.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/XES' title='SPDR S&P Oil & Gas Equipment & Services ETF'>XES</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/IEZ' title='iShares U.S. Oil Equipment & Services ETF'>IEZ</a>, <a href='https://seekingalpha.com/symbol/PXE' title='PowerShares Dynamic Energy Exploration & Production Portfolio ETF'>PXE</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/PXI' title='PowerShares DWA Energy Momentum Portfolio ETF'>PXI</a>, <a href='https://seekingalpha.com/symbol/RYE' title='Guggenheim S&P Equal Weight Energy ETF'>RYE</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/PXJ' title='PowerShares Dynamic Oil & Gas Services Portfolio ETF'>PXJ</a>, <a href='https://seekingalpha.com/symbol/PSCE' title='PowerShares S&P SmallCap Energy Portfolio ETF'>PSCE</a>, <a href='https://seekingalpha.com/symbol/FXN' title='First Trust Energy AlphaDEX ETF'>FXN</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/CRAK' title='VanEck Vectors Oil Refiners ETF'>CRAK</a>, <a href='https://seekingalpha.com/symbol/DDG' title='ProShares Short Oil & Gas ETF'>DDG</a>, <a href='https://seekingalpha.com/symbol/NANR' title='SPDR S&P North American Natural Resources ETF'>NANR</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a>, <a href='https://seekingalpha.com/symbol/JHME' title='John Hancock Multifactor Energy ETF'>JHME</a>, <a href='https://seekingalpha.com/symbol/XE' title='Elkhorn S&P MidCap Energy ETF'>XE</a>, <a href='https://seekingalpha.com/symbol/ERYY' title='Direxion Daily Energy Bear 1x Shares ETF'>ERYY</a>, <a href='https://seekingalpha.com/symbol/FTXN' title='First Trust Nasdaq Oil & Gas ETF'>FTXN</a>, <a href='https://seekingalpha.com/symbol/ERGF' title='iShares Edge MSCI Multifactor Energy ETF'>ERGF</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3295455\" data-linked=\"U.S. crude clears $50/bbl for first time in five weeks\" data-tweet=\"$XLE $USO $OIL - U.S. crude clears $50/bbl for first time in five weeks https://seekingalpha.com/news/3295455-u-s-crude-clears-50-bbl-for-first-time-in-five-weeks?source=tweet\" data-url=\"https://seekingalpha.com/news/3295455-u-s-crude-clears-50-bbl-for-first-time-in-five-weeks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>64&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295451\" data-ts=\"1505398110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CATB\" target=\"_blank\">CATB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295451-catabasis-to-present-data-from-extension-phase-of-dmd-med-edasalonexent-in-early-october\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catabasis to present data from extension phase of DMD med edasalonexent in early October; shares up 8%</a></h4><ul><li>Thinly traded nano cap Catabasis Pharmaceuticals (<a href='https://seekingalpha.com/symbol/CATB' title='Catabasis Pharmaceuticals'>CATB</a> <font color='green'>+7.6%</font>) adds to its recent up move on a healthy 6x surge in volume. Shares have rallied&nbsp;<font color='green'>28%</font>&nbsp;since August 24.</li><li>The company will <a href=\"https://seekingalpha.com/pr/16940669-catabasis-pharmaceuticals-present-results-open-label-extension-movedmd-phase-2-trial\" target=\"_blank\">present </a>24- and 36-week data on edasalonexent in boys with Duchenne muscular dystrophy at the 22nd International Congress of the World Muscle Society in France on Wednesday, October 4.</li><li>Edasalonexent, a small molecule inhibitor of a protein called NF-kB, has Orphan Drug, Fast Track and Rare Pediatric Disease status in the U.S. and Orphan Drug status in Europe.</li></ul><div class=\"tiny-share-widget\" data-id=\"3295451\" data-linked=\"Catabasis to present data from extension phase of DMD med edasalonexent in early October; shares up 8%\" data-tweet=\"$CATB - Catabasis to present data from extension phase of DMD med edasalonexent in early October; shares up 8% https://seekingalpha.com/news/3295451-catabasis-to-present-data-from-extension-phase-of-dmd-med-edasalonexent-in-early-october?source=tweet\" data-url=\"https://seekingalpha.com/news/3295451-catabasis-to-present-data-from-extension-phase-of-dmd-med-edasalonexent-in-early-october\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295447\" data-ts=\"1505397213\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAR\" target=\"_blank\">CAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295447-avis-falls-investment-firms-exude-caution\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avis falls as investment firms exude caution</a></h4><ul> <li>Avis Budget Group (<a href='https://seekingalpha.com/symbol/CAR' title='Avis Budget Group, Inc.'>CAR</a> <font color='red'>-6.2%</font>) falls after Morgan Stanley and Credit Suisse issue similar warnings on the car rental sector.</li> <li>The investment firms are reading off the same script today in saying that the rally for Avis and Hertz has been played out amid the \"challenged\" fundamental outlook.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3295371-morgan-stanley-sees-hertz-global-rally-played\" target=\"_blank\">Morgan Stanley sees Hertz Global rally played out</a> (Sept. 14)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3295447\" data-linked=\"Avis falls as investment firms exude caution\" data-tweet=\"$CAR - Avis falls as investment firms exude caution https://seekingalpha.com/news/3295447-avis-falls-investment-firms-exude-caution?source=tweet\" data-url=\"https://seekingalpha.com/news/3295447-avis-falls-investment-firms-exude-caution\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295441\" data-ts=\"1505396555\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALV\" target=\"_blank\">ALV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295441-splitting-trend-in-auto-supplier-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A splitting trend in the auto supplier sector</a></h4><ul> <li>The auto supplier sector is on watch after Autoliv (<a href='https://seekingalpha.com/symbol/ALV' title='Autoliv Inc.'>ALV</a>) says it's considering a plan to split its business in two. The new development follows Delphi's decision to separate its powertrain businesse with a spinoff.</li> <li>RBC Capital think other companies will feel some pressure from investors to make a similar move amid the electrification push in auto. Magna International (<a href='https://seekingalpha.com/symbol/MGA' title='Magna International Inc.'>MGA</a>), Tenneco (<a href='https://seekingalpha.com/symbol/TEN' title='Tenneco Inc.'>TEN</a>) and Lear (<a href='https://seekingalpha.com/symbol/LEA' title='Lear Corporation'>LEA</a>) top the RBC list.</li> <li>As for Autoliv, share have rocketed to a 52-week high of $127.58 and might not be done yet.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3295363-autoliv-evaluate-potential-business-split\" target=\"_blank\">Autoliv to evaluate potential business split</a> (Sept. 14)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3295441\" data-linked=\"A splitting trend in the auto supplier sector\" data-tweet=\"$ALV $ALV $MGA - A splitting trend in the auto supplier sector https://seekingalpha.com/news/3295441-splitting-trend-in-auto-supplier-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3295441-splitting-trend-in-auto-supplier-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295440\" data-ts=\"1505396530\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JONE\" target=\"_blank\">JONE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295440-jones-energyplus-13-shareholder-calls-for-strategic-alternatives\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jones Energy +13% as shareholder calls for strategic alternatives</a></h4><ul>     <li>Jones Energy (<a href='https://seekingalpha.com/symbol/JONE' title='Jones Energy, Inc.'>OTC:JONE</a>) skyrockets higher at the open after shareholder Q Investments calls on the company's board to immediately start a process to <a href=\"http://www.prnewswire.com/news-releases/q-investments-calls-for-jones-energy-to-immediately-start-a-process-to-explore-all-strategic-alternatives-including-selling-the-company-300519313.html\" target=\"_blank\">explore strategic alternatives</a>, including a potential sale of the company.</li>     <li>Q Investments says it will run its own slate of directors at Jones's upcoming annual meeting unless the company \"takes definitive steps.\"</li>     <li>Q says its affiliates directly hold a 5.7% stake in Jones via equity or shares convertible into equity with an additional 9.4% through swaps, for total exposure of 15%-plus of the company's common shares on a fully diluted basis.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3295440\" data-linked=\"Jones Energy +13% as shareholder calls for strategic alternatives\" data-tweet=\"$JONE - Jones Energy +13% as shareholder calls for strategic alternatives https://seekingalpha.com/news/3295440-jones-energyplus-13-shareholder-calls-for-strategic-alternatives?source=tweet\" data-url=\"https://seekingalpha.com/news/3295440-jones-energyplus-13-shareholder-calls-for-strategic-alternatives\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295434\" data-ts=\"1505395318\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295434-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/HALO' title='Halozyme Therapeutics, Inc.'>HALO</a> <font color='green'>+18%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3295368-halozyme-licenses-enhanze-roche-bristol-myers-455m-raises-guidance-shares-12-percent\" target=\"_blank\">out-licenses</a> ENHANZE to Roche and Bristol Myers for up to $455M.</li><li><a href='https://seekingalpha.com/symbol/SHIP' title='Seanergy Maritime Holdings Corp'>SHIP</a> <font color='green'>+19%</font>&nbsp;on Q2 <a href=\"https://seekingalpha.com/news/3295396-seanergy-maritime-reports-q2-results\" target=\"_blank\">results</a>.</li><li><a href='https://seekingalpha.com/symbol/ALV' title='Autoliv Inc.'>ALV</a> <font color='green'>+10%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3295363-autoliv-evaluate-potential-business-split\" target=\"_blank\">evaluating</a> potential business split.</li><li><a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a> <font color='green'>+9%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16940695-ekso-bionics-genesis-rehab-services-collaborate-entry-post-acute-care-settings\" target=\"_blank\">collaboration</a> to study opportunities for incorporating EksoGT&trade; in skilled nursing facilities.</li><li><a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color='green'>+8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3295423-analysts-weigh-possible-tenet-sale-shares-ahead-6-percent-premarket\" target=\"_blank\">evaluating</a> strategic alternatives, including an outright sale.</li><li><a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/symbol/XXII' title='22nd Century Group, Inc.'>XXII</a> <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/symbol/AEMD' title='Aethlon Medical, Inc.'>AEMD</a> <font color='green'>+6%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16940588-aethlon-medical-receives-national-cancer-institute-contract-award\" target=\"_blank\">receiving</a> national cancer institute contract award.</li><li><a href='https://seekingalpha.com/symbol/AGEN' title='Agenus'>AGEN</a> <font color='green'>+6%</font>.</li><li><a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a> <font color='green'>+6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3295434\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$HALO $SHIP $ALV - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3295434-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3295434-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295432\" data-ts=\"1505395148\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295432-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/SMMT' title='Summit Therapeutics'>SMMT</a>&nbsp;<font color='red'>-19%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3295413-summit-therapeutics-prices-ads-offering-12-shares-16-percent-premarket\" target=\"_blank\">pricing</a> 1.5M ADSs.</li><li><a href='https://seekingalpha.com/symbol/BVXV' title='Biondvax Pharmaceuticals'>BVXV</a>&nbsp;<font color='red'>-15%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3295418-biondvax-prices-public-offering-1_5m-ads-offering-6-shares-16-percent-premarket\" target=\"_blank\">pricing</a>&nbsp;ADSs offering at $6.</li><li><a href='https://seekingalpha.com/symbol/GKOS' title='Glaukos'>GKOS</a>&nbsp;<font color='red'>-10%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3295380-glaukos-outline-growth-strategy-investor-day-lowers-guidance\" target=\"_blank\">lowering</a> guidance and outlining growth strategy at Investor day.</li><li><a href='https://seekingalpha.com/symbol/NYRT' title='New York REIT'>NYRT</a>&nbsp;<font color='red'>-10%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3295403-new-york-reit-deal-sale-49-percent-worldwide-plaza-shares-6_4-percent\" target=\"_blank\">selling</a> ~49% interest in Worldwide Plaza to a joint venture managed by SL Green and RXR Realty.</li><li><a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3295286-array-readies-equity-offering-shares-8-percent-hours\" target=\"_blank\">announcing</a> proposed public offering of common stock.</li><li><a href='https://seekingalpha.com/symbol/EPZM' title='Epizyme'>EPZM</a>&nbsp;<font color='red'>-7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3295359-epizyme-prices-public-offering-common-stock\" target=\"_blank\">pricing</a> 9.2M shares of common stock.</li><li><a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a>&nbsp;<font color='red'>-6%</font>&nbsp;on Morgan Stanley <a href=\"https://seekingalpha.com/news/3295371-morgan-stanley-sees-hertz-global-rally-played\" target=\"_blank\">lowering</a> Hertz to Underweight.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3295432\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$SMMT $BVXV $GKOS - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3295432-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3295432-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295431\" data-ts=\"1505395028\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LSCC\" target=\"_blank\">LSCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295431-craig-hallum-lowers-lattice-semiconductor-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Craig-Hallum lowers Lattice Semiconductor price target</a></h4><ul><li>        Craig-Hallum <a href=\"https://www.streetinsider.com/Analyst+Comments/Lattice+Semiconductor+%28LSCC%29+PT+Lowered+to+%246+at+Craig-Hallum/13295342.html\" target=\"_blank\">lowers</a> its Lattice Semiconductor (NASDAQ:<a href='https://seekingalpha.com/symbol/LSCC' title='Lattice Semiconductor Corporation'>LSCC</a>) price target from $8.30 to $6 while maintaining a Hold rating.</li><li>               The cut comes after President Trump rejected the acquisition of the company by Chinese private equity firm Canyon Bridge Capital Partners.&nbsp;</li><li>                  Lattice Semiconductor shares are&nbsp;<font color='red'>down 2.1%</font>&nbsp;premarket. &nbsp;&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3295265-trump-blocks-chinese-semiconductor-acquisition\" target=\"_blank\">Trump blocks Chinese semiconductor acquisition</a> (Sept. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3295431\" data-linked=\"Craig-Hallum lowers Lattice Semiconductor price target\" data-tweet=\"$LSCC - Craig-Hallum lowers Lattice Semiconductor price target https://seekingalpha.com/news/3295431-craig-hallum-lowers-lattice-semiconductor-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3295431-craig-hallum-lowers-lattice-semiconductor-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295430\" data-ts=\"1505394650\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YUMA\" target=\"_blank\">YUMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295430-yuma-energy-to-launch-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yuma Energy to launch stock offering</a></h4><ul>     <li>Yuma Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/YUMA' title='Yuma Energy, Inc.'>YUMA</a>) <font color='red'>-10.4%</font> premarket after commencing a <a href=\"https://seekingalpha.com/pr/16940273-yuma-energy-inc-announces-proposed-public-offering-common-stock\" target=\"_blank\">public offering</a> of an unspecified number of common shares.</li>     <li>Yuma plans to use the proceeds to provide for additional leasehold acquisitions in the Permian Basin, the drilling of a San Andres horizontal well along with a Devonian salt water disposal well and other field infrastructure, and for general working capital purposes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3295430\" data-linked=\"Yuma Energy to launch stock offering\" data-tweet=\"$YUMA - Yuma Energy to launch stock offering https://seekingalpha.com/news/3295430-yuma-energy-to-launch-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3295430-yuma-energy-to-launch-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295423\" data-ts=\"1505394592\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/THC\" target=\"_blank\">THC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295423-analysts-weigh-in-on-possible-tenet-sale-shares-ahead-6-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More analysts weigh in on possible Tenet sale; shares ahead 6% premarket</a></h4><ul><li>Tenet Healthcare (NYSE:<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a>) is up&nbsp;<font color='green'>6%</font>&nbsp;premarket on robust volume on the heels of a report that it is evaluating strategic alternatives, including an outright sale.</li><li>Sampling of comments from sell-siders:</li><li>Mizuho's Sheryl Skolnick: sees $25 price tag for THC, 3% dilution for HCA. Antitrust likely to be an issue (NEUTRAL/$14).</li><li>Deutsche Bank's Chris Rigg: Private equity buyer makes more sense. Divestment of Conifer would not be a good value generator since it would eliminate a major contributor to cash flow. Outpatient unit USPI would be left as standalone company.</li><li>Baird's Whit Mayo: Potential USPI sale is a \"synthetic poison pill\" because it creates channel conflict for any obvious strategic buyer (OUTPERFORM/$23).</li><li>Suntrust's David Macdonald: Non-hospital assets more valuable - generate almost 40% of non-GAAP EBITDA. Number of public suitors limited though (HOLD/$16).</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3295291-wsj-reports-tenet-mulling-sale-shares-15-percent-hours\" target=\"_blank\">WSJ reports Tenet mulling sale; shares up 15% after hours</a> (Sept. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3295423\" data-linked=\"More analysts weigh in on possible Tenet sale; shares ahead 6% premarket\" data-tweet=\"$THC - More analysts weigh in on possible Tenet sale; shares ahead 6% premarket https://seekingalpha.com/news/3295423-analysts-weigh-in-on-possible-tenet-sale-shares-ahead-6-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3295423-analysts-weigh-in-on-possible-tenet-sale-shares-ahead-6-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295427\" data-ts=\"1505394178\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WLH\" target=\"_blank\">WLH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295427-william-lyon-homes-down-3_5-paulson-lightens-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">William Lyon Homes down 3.5% as Paulson lightens up</a></h4><ul><li>Sold were 3.3M shares owned by Paulson &amp; Co. Credit Suisse is the underwriter.</li><li>The sale comes after a&nbsp;<font color='green'>near-50% Y/Y run higher</font>&nbsp;for the stock. <a href='https://seekingalpha.com/symbol/WLH' title='William Lyon Homes'>WLH</a>&nbsp;<font color='red'>-3.5%&nbsp;</font>premarket</li><li>Source: <a href=\"https://seekingalpha.com/pr/16940322-william-b-lyon-b-homes-announces-pricing-secondary-offering-3322-666-shares-class-common\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3295427\" data-linked=\"William Lyon Homes down 3.5% as Paulson lightens up\" data-tweet=\"$WLH - William Lyon Homes down 3.5% as Paulson lightens up https://seekingalpha.com/news/3295427-william-lyon-homes-down-3_5-paulson-lightens-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3295427-william-lyon-homes-down-3_5-paulson-lightens-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295422\" data-ts=\"1505394115\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRIS\" target=\"_blank\">CRIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295422-curis-prices-stock-offering-doesnt-disclose-price\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Curis prices stock offering but doesn&#39;t disclose price</a></h4><ul> <li>Curis (NASDAQ:<a href='https://seekingalpha.com/symbol/CRIS' title='Curis, Inc.'>CRIS</a>)&nbsp;<a href=\"https://seekingalpha.com/pr/16940550-curis-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices</a> an underwritten public offering of 20M shares of its common stock, but the actual price is nowhere to be found.</li><li>Underwriters over-allotment is an additional 3M shares.</li>     <li>Net proceeds will be used to continue development of CUDC-907, CA-170, CA-327 and CA-4948, to fund potential acquisitions of new business, technologies or products and for general working capital and capital expenditures.</li><li>Closing date is September 18.</li><li>Yesterday's close was $2.00.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3295422\" data-linked=\"Curis prices stock offering but doesn&#39;t disclose price\" data-tweet=\"$CRIS - Curis prices stock offering but doesn&#39;t disclose price https://seekingalpha.com/news/3295422-curis-prices-stock-offering-doesnt-disclose-price?source=tweet\" data-url=\"https://seekingalpha.com/news/3295422-curis-prices-stock-offering-doesnt-disclose-price\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295419\" data-ts=\"1505393344\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RWLK\" target=\"_blank\">RWLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295419-rewalk-robotics-exoskeletons-to-be-covered-leading-german-health-insurer-shares-up-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ReWalk Robotics exoskeletons to be covered by leading German health insurer; shares up 7% premarket</a></h4><ul><li>Thinly traded nano cap ReWalk Robotics (NASDAQ:<a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics'>RWLK</a>) is up&nbsp;<font color='green'>7%</font>&nbsp;premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/16940747-payer-coverage-rewalk-expands-germany-barmer\" target=\"_blank\">announcement </a>that German health insurer Barmer will cover its exoskeletons for all qualifying beneficiaries.</li><li>Barmer is already processing claims for three patients.</li></ul><div class=\"tiny-share-widget\" data-id=\"3295419\" data-linked=\"ReWalk Robotics exoskeletons to be covered by leading German health insurer; shares up 7% premarket\" data-tweet=\"$RWLK - ReWalk Robotics exoskeletons to be covered by leading German health insurer; shares up 7% premarket https://seekingalpha.com/news/3295419-rewalk-robotics-exoskeletons-to-be-covered-leading-german-health-insurer-shares-up-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3295419-rewalk-robotics-exoskeletons-to-be-covered-leading-german-health-insurer-shares-up-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295418\" data-ts=\"1505393312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BVXV\" target=\"_blank\">BVXV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295418-biondvax-prices-public-offering-of-1_5m-ads-offering-6-shares-down-16-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BiondVax prices public offering of 1.5M ADS offering at $6; shares down 16% premarket</a></h4><ul> <li>BiondVax Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/BVXV' title='Biondvax Pharmaceuticals'>BVXV</a>) <a href=\"https://seekingalpha.com/pr/16940337-biondvax-announces-pricing-public-offering-american-depositary-shares\" target=\"_blank\">prices</a> an underwritten public offering of 1.5M ADSs, each ADS representing 40 of its ordinary shares at a price of $6.00 per ADS.</li> <li>Underwriters over-allotment is an additional 166,667 ADSs.</li><li>Closing date is September 18.</li><li>Shares are down&nbsp;<font color='red'>16%</font>&nbsp;premarket on robust volume. Yesterday's close was $7.63.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3295418\" data-linked=\"BiondVax prices public offering of 1.5M ADS offering at $6; shares down 16% premarket\" data-tweet=\"$BVXV - BiondVax prices public offering of 1.5M ADS offering at $6; shares down 16% premarket https://seekingalpha.com/news/3295418-biondvax-prices-public-offering-of-1_5m-ads-offering-6-shares-down-16-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3295418-biondvax-prices-public-offering-of-1_5m-ads-offering-6-shares-down-16-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295420\" data-ts=\"1505393292\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTCS\" target=\"_blank\">BTCS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295420-bitcoin-extends-losses-after-one-chinese-exchange-sets-shutdown\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitcoin extends losses after one Chinese exchange sets shutdown</a></h4><ul><li>BTC China is one of the country's top three bitcoin exchanges. After carefully considering instructions from Beijing from earlier this month, <a href=\"https://twitter.com/YourBTCC\" target=\"_blank\">the company says </a>it will stop all trading on September 30.</li><li>Bitcoin is now<font color='red'> lower by 7%&nbsp;</font>on the session at $3,600.</li><li><a href='https://seekingalpha.com/symbol/BTCS' title='BTCS Inc.'>OTCQB:BTCS</a>, <a href='https://seekingalpha.com/symbol/BTSC' title='Bitcoin Services, Inc.'>OTCPK:BTSC</a>. <a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>, <a href='https://seekingalpha.com/symbol/ARSC' title='American Security Resources Corp.'>OTC:ARSC</a>, <a href='https://seekingalpha.com/symbol/GAHC' title='Global Arena Holding, Inc.'>OTCPK:GAHC</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3294488-report-china-shut-digital-currency-exchanges\" target=\"_blank\">Report: China to shut digital currency exchanges</a> (Sept. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3295420\" data-linked=\"Bitcoin extends losses after one Chinese exchange sets shutdown\" data-tweet=\"$BTCS $BTCS $BTSC - Bitcoin extends losses after one Chinese exchange sets shutdown https://seekingalpha.com/news/3295420-bitcoin-extends-losses-after-one-chinese-exchange-sets-shutdown?source=tweet\" data-url=\"https://seekingalpha.com/news/3295420-bitcoin-extends-losses-after-one-chinese-exchange-sets-shutdown\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295416\" data-ts=\"1505392953\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295416-base-metals-miners-lose-ground-amid-signs-of-slowing-china-economy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Base metals miners lose ground amid signs of slowing China economy</a></h4><ul>     <li>Shares of global miners are <a href=\"http://www.marketwatch.com/story/european-stocks-pull-back-after-signs-chinas-economy-is-faltering-2017-09-14\" target=\"_blank\">poised for sharp losses</a> after China reported a <a href=\"https://seekingalpha.com/news/3295327-chinas-economy-losing-steam\" target=\"_blank\">surprise slowdown</a> in business activity during August: <a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='red'>-3.1%</font>, <a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a> <font color='red'>-2.7%</font>, <a href='https://seekingalpha.com/symbol/BHP' title='BHP Billiton Limited'>BHP</a> <font color='red'>-2.2%</font> premarket.</li>     <li>China's value-added industrial output, a rough proxy for economic growth, <a href=\"http://www.abc.net.au/news/2017-09-14/china-economy-starts-to-soften-again/8945242\" target=\"_blank\">slowed for a second straight month</a>, rising 6% in August vs. a 6.4% increase in July, and growth in investments was the slowest in nearly 18 years.</li>     <li><a href=\"http://www.marketwatch.com/story/copper-slides-after-chinese-data-disappoints-2017-09-14\" target=\"_blank\">Copper is lower again</a> following the data, and prices have now unwound by more than 7% since hitting their three-year peak on Sept. 6.</li><li>With margin-seeking investors selling their copper holdings in to LME warehouses, stocks increased another 16% during today's trade, according to data from commodities broker Marex Spectron.</li><li>Other relevant tickers include <a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a>, <a href='https://seekingalpha.com/symbol/TECK' title='Teck Resources Limited'>TECK</a>, <a href='https://seekingalpha.com/symbol/SCCO' title='Southern Copper Corporation'>SCCO</a>, <a href='https://seekingalpha.com/symbol/GLCNF' title='Glencore Plc'>OTCPK:GLCNF</a>, <a href='https://seekingalpha.com/symbol/GLNCY' title='Glencore Plc ADR'>OTCPK:GLNCY</a>, <a href='https://seekingalpha.com/symbol/AAUKF' title='Anglo American plc'>OTCQX:AAUKF</a>, <a href='https://seekingalpha.com/symbol/AAUKY' title='Anglo American plc ADR'>OTCPK:AAUKY</a>, <a href='https://seekingalpha.com/symbol/ANFGF' title='Antofagasta plc'>OTC:ANFGF</a>, <a href='https://seekingalpha.com/symbol/ANFGY' title='Antofagasta plc ADR'>OTCPK:ANFGY</a></li><li>ETFs: <a href='https://seekingalpha.com/symbol/JJC' title='iPath Series B Bloomberg Copper Subindex Total Return ETN'>JJC</a>, <a href='https://seekingalpha.com/symbol/DBB' title='Invesco DB Base Metals ETF'>DBB</a>, <a href='https://seekingalpha.com/symbol/JJN' title='iPath DJ-UBS Nickel Total Return Sub-Index ETN'>JJN</a>, <a href='https://seekingalpha.com/symbol/CPER' title='United States Copper Index ETF'>CPER</a>, <a href='https://seekingalpha.com/symbol/JJU-OLD' title='iPath Dow Jones-UBS Aluminum Total Return Sub-IndexS ETN'>JJU-OLD</a>, <a href='https://seekingalpha.com/symbol/BOM' title='DB Base Metals Double Short ETN'>BOM</a>, <a href='https://seekingalpha.com/symbol/JJT-OLD' title='iPath Dow Jones-UBS Tin Total Return Sub-Index ETN'>JJT-OLD</a>, <a href='https://seekingalpha.com/symbol/BOS' title='DB Base Metals Short ETN'>BOS</a>, <a href='https://seekingalpha.com/symbol/NINI' title='iPath Pure Beta Nickel ETN'>NINI</a>, <a href='https://seekingalpha.com/symbol/LD' title='iPath Dow Jones-UBS Lead Total Return Sub-Index ETN'>LD</a>, <a href='https://seekingalpha.com/symbol/JJM' title='iPath DJ-UBS Industrial Metals Total Return Sub-Index ETN'>JJM</a>, <a href='https://seekingalpha.com/symbol/CUPM' title='iPath Pure Beta Copper ETN'>CUPM</a>, <a href='https://seekingalpha.com/symbol/BDD' title='DB Base Metals Double Long ETN'>BDD</a>, <a href='https://seekingalpha.com/symbol/FOIL' title='iPath Pure Beta Aluminum ETN'>FOIL</a>, <a href='https://seekingalpha.com/symbol/RJZ' title='ELEMENTS Rogers International Commodity Metal ETN'>RJZ</a>, <a href='https://seekingalpha.com/symbol/BDG-OLD' title='DB Base Metals Long ETN'>BDG-OLD</a>, <a href='https://seekingalpha.com/symbol/UBM' title='UBS ETRACS CMCI Industrial Metals Total Return ETN'>UBM</a>, <a href='https://seekingalpha.com/symbol/LEDD' title='iPath Pure Beta Lead ETN'>LEDD</a>, <a href='https://seekingalpha.com/symbol/HEVY' title='iPath Pure Beta Industrial Metals ETN'>HEVY</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3295416\" data-linked=\"Base metals miners lose ground amid signs of slowing China economy\" data-tweet=\"$VALE $VALE $RIO - Base metals miners lose ground amid signs of slowing China economy https://seekingalpha.com/news/3295416-base-metals-miners-lose-ground-amid-signs-of-slowing-china-economy?source=tweet\" data-url=\"https://seekingalpha.com/news/3295416-base-metals-miners-lose-ground-amid-signs-of-slowing-china-economy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295413\" data-ts=\"1505392702\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMMT\" target=\"_blank\">SMMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295413-summit-therapeutics-prices-ads-offering-12-shares-down-16-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Summit Therapeutics prices ADS offering at $12; shares down 16% premarket</a></h4><ul> <li>Summit Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SMMT' title='Summit Therapeutics'>SMMT</a>) <a href=\"https://seekingalpha.com/pr/16940364-summit-therapeutics-announces-pricing-public-offering-1459-000-american-depositary-shares\" target=\"_blank\">prices</a> its underwritten public offering of 1.5M ADSs at an offering price of $12.00 per ADS for gross proceeds of ~$17.5M. Each ADS represents five ordinary shares of Summit.</li>   <li>Also, underwriters are granted a 30 days option to purchase up to 218,850 additional ADSs.</li><li>Closing date is September 18.</li><li>Shares are off&nbsp;<font color='red'>16%</font>&nbsp;premarket. Yesterday's close was $15.25</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3295413\" data-linked=\"Summit Therapeutics prices ADS offering at $12; shares down 16% premarket\" data-tweet=\"$SMMT - Summit Therapeutics prices ADS offering at $12; shares down 16% premarket https://seekingalpha.com/news/3295413-summit-therapeutics-prices-ads-offering-12-shares-down-16-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3295413-summit-therapeutics-prices-ads-offering-12-shares-down-16-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295403\" data-ts=\"1505391649\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLG\" target=\"_blank\">SLG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295403-new-york-reit-in-deal-for-sale-of-49-of-worldwide-plaza-shares-down-6_4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New York REIT in deal for sale of 49% of Worldwide Plaza; shares down 6.4%</a></h4><ul><li>The agreement calls for the sale of a 48.7% interest in Worldwide Plaza to a JV managed by SL Green (NYSE:<a href='https://seekingalpha.com/symbol/SLG' title='SL Green Realty Corporation'>SLG</a>) and RXR Realty, valuing the entire property at $1.725B (roughly inline with what had been previously estimated).</li><li>New York REIT (NYSE:<a href='https://seekingalpha.com/symbol/NYRT' title='New York REIT'>NYRT</a>) will receive $346.2M at closing, and will continue to own 50.1% of the property.</li><li>The deal is expected to close on or before Nov. 3.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16940745-new-york-reit-sells-approximately-49-percent-interest-worldwide-plaza-joint-venture-managed\" target=\"_blank\">Press Release</a></li><li>Shares&nbsp;<font color='red'>-6.4%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3295403\" data-linked=\"New York REIT in deal for sale of 49% of Worldwide Plaza; shares down 6.4%\" data-tweet=\"$SLG $SLG $NYRT - New York REIT in deal for sale of 49% of Worldwide Plaza; shares down 6.4% https://seekingalpha.com/news/3295403-new-york-reit-in-deal-for-sale-of-49-of-worldwide-plaza-shares-down-6_4?source=tweet\" data-url=\"https://seekingalpha.com/news/3295403-new-york-reit-in-deal-for-sale-of-49-of-worldwide-plaza-shares-down-6_4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>67&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295402\" data-ts=\"1505391523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUE\" target=\"_blank\">NUE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295402-nucor-upgraded-to-buy-citi-on-attractive-valuation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nucor upgraded to Buy at Citi on attractive valuation</a></h4><ul>     <li>Nucor (NYSE:<a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a>)&nbsp;<font color='green'>+1.4%</font>&nbsp;premarket after Citigroup <a href=\"https://www.streetinsider.com/Analyst+Comments/Citi+Upgrades+Nucor+%28NUE%29+to+Buy/13295401.html\" target=\"_blank\">upgrades shares to Buy</a> from Neutral with a $65 price target, citing what it sees as a disconnect between NUE&rsquo;s lackluster share price and the underlying fundamentals of the sector.</li>     <li>U.S. steel prices in key products such as HRC, bars and rods appear well supported given significant lags to global pricing, Citi says; for example, U.S. rebar is now cheaper than Chinese and European rebar.</li>     <li>Citi remains neutral on the broader steel sector (NYSEARCA:<a href='https://seekingalpha.com/symbol/SLX' title='VanEck Vectors Steel ETF'>SLX</a>) due to end-market risks from slowing auto markets and peaking rig counts; the firm rates NUE, Steel Dynamics (NASDAQ:<a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a>) and Commercial Metals (NYSE:<a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a>) at Buy, AK&nbsp;Steel (NYSE:<a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a>) at Neutral and U.S. Steel (NYSE:<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a>) as a Sell.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3295402\" data-linked=\"Nucor upgraded to Buy at Citi on attractive valuation\" data-tweet=\"$NUE $NUE $SLX - Nucor upgraded to Buy at Citi on attractive valuation https://seekingalpha.com/news/3295402-nucor-upgraded-to-buy-citi-on-attractive-valuation?source=tweet\" data-url=\"https://seekingalpha.com/news/3295402-nucor-upgraded-to-buy-citi-on-attractive-valuation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295400\" data-ts=\"1505391373\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USFD\" target=\"_blank\">USFD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295400-us-foods-announces-secondary-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">US foods announces secondary offering</a></h4><ul>          <li>US Foods Holding (NYSE:<a href='https://seekingalpha.com/symbol/USFD' title='US Foods Holding'>USFD</a>) announces an offering of 40M&nbsp;shares held by investment funds       associated with Clayton, Dubilier &amp; Rice and Kohlberg Kravis       Roberts &amp; Co.</li>     <li>US Foods will not       receive any proceeds from the sale of the shares in the offering.</li><li>Bloomberg reports the pricing on the share offering is at $27.50.</li>     <li>USFD  <font color='red'>-2.86%</font> premarket to  $27.21.</li>     <li>Source: <a href=\"https://seekingalpha.com/pr/16940217-us-foods-announces-secondary-public-offering-common-stock\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3295400\" data-linked=\"US foods announces secondary offering\" data-tweet=\"$USFD - US foods announces secondary offering https://seekingalpha.com/news/3295400-us-foods-announces-secondary-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3295400-us-foods-announces-secondary-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295368\" data-ts=\"1505389176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HALO\" target=\"_blank\">HALO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295368-halozyme-out-licenses-enhanze-to-roche-and-bristol-myers-for-up-to-455m-raises-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Halozyme out-licenses ENHANZE to Roche and Bristol Myers for up to $455M; raises guidance; shares up 12% premarket</a></h4><ul><li>Halozyme (NASDAQ:<a href='https://seekingalpha.com/symbol/HALO' title='Halozyme Therapeutics, Inc.'>HALO</a>) is up&nbsp;<font color='green'>12%</font>&nbsp;premarket in response to its <a href=\"https://seekingalpha.com/pr/16940576-halozyme-licenses-new-enhanze-target-30-million-upfront-payment-future-milestones-royalties\" target=\"_blank\">announcement </a>that it has out-licensed its ENHANZE drug-delivery technology to Roche (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding Ltd ADR'>OTCQX:RHHBY</a>) for exclusive development of an undisclosed therapeutic target.</li><li>Under the terms of the deal, HALO will receive $30M upfront, up to $160M in milestones and tiered mid-single-digit royalties on net sales.</li><li>The companies have had a business relationship since 2006. Roche has already developed two subcutaneous formulations of cancer drugs. Recently, the partnership included the clinical study of HALO's PEGPH20 with TECENTRIQ (atezolizumab).</li><li>The company has also <a href=\"https://seekingalpha.com/pr/16940526-bristol-myers-squibb-halozyme-enter-global-collaboration-license-agreement-enhanze-technology\" target=\"_blank\">out-licensed</a> ENHANZE to Bristol-Myers Squibb (NYSE:<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a>) in a deal valued up to $265M with the potential for an additional $1.6B if BMY chooses 10 additional targets. HALO will receive $105M upfront, milestones up to $160M and royalties on net sales.</li><li><a href=\"http://www.halozyme.com/technology-and-products/technology/enhanze-technology/default.aspx\" target=\"_blank\">ENHANZE </a>is based on HALO's patented recombinant human hyaluronidase enzyme (rHuPH20). It enables certain biologics and other compounds to be delivered via injections under the skin with the aim of providing a more patient-friendly experience.</li><li>Halozyme has <a href=\"https://seekingalpha.com/pr/16940577-halozyme-increases-2017-financial-guidance\" target=\"_blank\">raised </a>its 2017 financial guidance to include the upfront payments. Net revenue should be $245M - 260M, up from $115M - 130M. Cash flow ops will be positive $50M - 60M, up from cash consumption of $75M - 85M. Operating expenses of $240M - 250M will remain unchanged.</li></ul><div class=\"tiny-share-widget\" data-id=\"3295368\" data-linked=\"Halozyme out-licenses ENHANZE to Roche and Bristol Myers for up to $455M; raises guidance; shares up 12% premarket\" data-tweet=\"$HALO $HALO $RHHBY - Halozyme out-licenses ENHANZE to Roche and Bristol Myers for up to $455M; raises guidance; shares up 12% premarket https://seekingalpha.com/news/3295368-halozyme-out-licenses-enhanze-to-roche-and-bristol-myers-for-up-to-455m-raises-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3295368-halozyme-out-licenses-enhanze-to-roche-and-bristol-myers-for-up-to-455m-raises-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295371\" data-ts=\"1505389072\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTZ\" target=\"_blank\">HTZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295371-morgan-stanley-sees-hertz-global-rally-played-out\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley sees Hertz Global rally played out</a></h4><ul> <li>Morgan Stanley sees a negative impact on car rental pricing for Hertz Global (NYSE:<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a>) from the hurricanes as it calls out a good exit point for investors.</li> <li>Shares of Hertz are up 150% over the last 90 days, a powerful run that MS thinks has played out due to the challenged fundamental outlook for the car rental company.</li><li>The investment firm lowers Hertz to Underweight and sets a price target of $14.</li> <li>Souece: Bloomberg</li> <li>HTZ <font color='red'>-4.93%</font> premarket to $22.75.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3295371\" data-linked=\"Morgan Stanley sees Hertz Global rally played out\" data-tweet=\"$HTZ - Morgan Stanley sees Hertz Global rally played out https://seekingalpha.com/news/3295371-morgan-stanley-sees-hertz-global-rally-played-out?source=tweet\" data-url=\"https://seekingalpha.com/news/3295371-morgan-stanley-sees-hertz-global-rally-played-out\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295365\" data-ts=\"1505387834\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295365-bank-of-england-on-hold-pound-rallies-on-hint-of-future-rate-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bank of England on hold; pound rallies on hint of future rate boost</a></h4><ul><li>The vote to hold policy in place was 7-2.</li><li><a href=\"http://www.bankofengland.co.uk/publications/Pages/news/2017/006.aspx\" target=\"_blank\">From the statement</a>: \"Some withdrawal of monetary stimulus is likely to be appropriate over the coming months.\"</li><li>The pound (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXB' title='CurrencyShares British Pound Sterling Trust ETF'>FXB</a>) has<font color='green'> jumped 0.6%</font>&nbsp;vs. the dollar to $1.3288. Stocks in the U.K. are flat.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EWU' title='iShares MSCI United Kingdom ETF'>EWU</a>, <a href='https://seekingalpha.com/symbol/DBUK' title='Deutsche X-trackers MSCI United Kingdom Hedged Equity ETF'>DBUK</a>, <a href='https://seekingalpha.com/symbol/FKU' title='First Trust United Kingdom AlphaDex ETF'>FKU</a>, <a href='https://seekingalpha.com/symbol/EWUS' title='iShares MSCI United Kingdom Small Cap Index ETF'>EWUS</a>, <a href='https://seekingalpha.com/symbol/DXPS' title='WisdomTree United Kingdom Hedged Equity ETF'>DXPS</a>, <a href='https://seekingalpha.com/symbol/HEWU' title='iShares Currency Hedged MSCI United Kingdom ETF'>HEWU</a>, <a href='https://seekingalpha.com/symbol/QGBR' title='SPDR MSCI United Kingdom Quality Mix ETF'>QGBR</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3295365\" data-linked=\"Bank of England on hold; pound rallies on hint of future rate boost\" data-tweet=\"$FXB $EWU $DBUK - Bank of England on hold; pound rallies on hint of future rate boost https://seekingalpha.com/news/3295365-bank-of-england-on-hold-pound-rallies-on-hint-of-future-rate-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3295365-bank-of-england-on-hold-pound-rallies-on-hint-of-future-rate-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295359\" data-ts=\"1505387757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EPZM\" target=\"_blank\">EPZM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295359-epizyme-prices-public-offering-of-common-stock\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Epizyme prices public offering of common stock</a></h4><ul> <li>Epizyme (NASDAQ:<a href='https://seekingalpha.com/symbol/EPZM' title='Epizyme'>EPZM</a>) <a href=\"https://seekingalpha.com/pr/16940507-epizyme-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices</a> an underwritten public offering of 9.2M shares of its common stock at a price of $15.25 per share. Underwriters over-allotment is an additional 1.4M shares.</li>   <li>Net proceeds will fund global development and commercialization costs of tazemetostat;&nbsp;to initiate supply chain and market development activities and for working capital and other general corporate purposes.</li>    <li>Closing date is September 18.</li><li>Yesterday's close was $15.95.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3295359\" data-linked=\"Epizyme prices public offering of common stock\" data-tweet=\"$EPZM - Epizyme prices public offering of common stock https://seekingalpha.com/news/3295359-epizyme-prices-public-offering-of-common-stock?source=tweet\" data-url=\"https://seekingalpha.com/news/3295359-epizyme-prices-public-offering-of-common-stock\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3295357\" data-ts=\"1505386923\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/THC\" target=\"_blank\">THC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3295357-tenet-not-see-buyer-for-whole-company-rbc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tenet does not see a buyer for the whole company - RBC</a></h4><ul><li>In a note, RBC Capital Markets says Tenet Healthcare (NYSE:<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a>) does not expect to find a buyer for the entire organization considering the high degree of leverage.</li><li>The ambulatory business is likely the most attractive either as an outright sale or a spinoff once Tenet attains full ownership (currently 80%), but potential suitors may be put off by the presence of one highly dominant customer (Tenet).</li><li>HCA may be interested in certain markets, but unlikely interested in entire hospital portfolio.</li><li>Any deal will be complex and require time to execute.</li><li>THC is up&nbsp;<font color='green'>12%</font>&nbsp;premarket on average volume.</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3295291-wsj-reports-tenet-mulling-sale-shares-15-percent-hours\" target=\"_blank\">WSJ reports Tenet mulling sale; shares up 15% after hours</a> (Sept. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3295357\" data-linked=\"Tenet does not see a buyer for the whole company - RBC\" data-tweet=\"$THC - Tenet does not see a buyer for the whole company - RBC https://seekingalpha.com/news/3295357-tenet-not-see-buyer-for-whole-company-rbc?source=tweet\" data-url=\"https://seekingalpha.com/news/3295357-tenet-not-see-buyer-for-whole-company-rbc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:02 AM </div></div></li>","count":68,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}